US20220325708A1 - Alternating tangential flow rapid harvesting - Google Patents

Alternating tangential flow rapid harvesting Download PDF

Info

Publication number
US20220325708A1
US20220325708A1 US17/731,295 US202217731295A US2022325708A1 US 20220325708 A1 US20220325708 A1 US 20220325708A1 US 202217731295 A US202217731295 A US 202217731295A US 2022325708 A1 US2022325708 A1 US 2022325708A1
Authority
US
United States
Prior art keywords
atf
bioreactor
harvest
volume
fed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
US17/731,295
Inventor
Shashi Kiran Kudugunti
WengLong Roy Lin
John Bonham-Carter
James R. Rusche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Repligen Corp
Original Assignee
Repligen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repligen Corp filed Critical Repligen Corp
Priority to US17/731,295 priority Critical patent/US20220325708A1/en
Assigned to REPLIGEN CORPORATION reassignment REPLIGEN CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LIN, Wenglong Roy, RUSCHE, JAMES R., BONHAM-CARTER, John, KUDUGUNTI, Shashi Kiran
Publication of US20220325708A1 publication Critical patent/US20220325708A1/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/04Cell isolation or sorting
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14Ultrafiltration; Microfiltration
    • B01D61/145Ultrafiltration
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D63/00Apparatus in general for separation processes using semi-permeable membranes
    • B01D63/02Hollow fibre modules
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D65/00Accessories or auxiliary operations, in general, for separation processes or apparatus using semi-permeable membranes
    • B01D65/08Prevention of membrane fouling or of concentration polarisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/34Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/04Filters; Permeable or porous membranes or plates, e.g. dialysis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/10Perfusion
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/16Hollow fibers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M33/00Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
    • C12M33/14Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus with filters, sieves or membranes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/48Automatic or computerized control
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/10Separation or concentration of fermentation products
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04BPOSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B43/00Machines, pumps, or pumping installations having flexible working members
    • F04B43/02Machines, pumps, or pumping installations having flexible working members having plate-like flexible members, e.g. diaphragms
    • F04B43/06Pumps having fluid drive
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04BPOSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B53/00Component parts, details or accessories not provided for in, or of interest apart from, groups F04B1/00 - F04B23/00 or F04B39/00 - F04B47/00
    • F04B53/16Casings; Cylinders; Cylinder liners or heads; Fluid connections
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2315/00Details relating to the membrane module operation
    • B01D2315/10Cross-flow filtration
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2321/00Details relating to membrane cleaning, regeneration, sterilization or to the prevention of fouling
    • B01D2321/20By influencing the flow
    • B01D2321/2083By reversing the flow
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00Cells for large scale production

Definitions

  • the invention relates to the use of alternating tangential flow filtration units for harvesting products from bioreactors, e.g., for harvesting of products from fed-batch bioreactor cultures.
  • Cultures of microbial, plant, or animal cells are used to produce biological and chemical substances of significant commercial value. Particularly for commercial production, these cultures can be run in three operational modes: batch, continuous, fed-batch, or concentrated fed-batch.
  • Applications include fermentation, biotechnology, and chemical, for production of specialty chemicals and products, as well as waste-treatment.
  • the products are typically high-value products that include any desired cellular products, such as endogenous and recombinant products, including proteins, peptides, nucleic acids, virus, amino acids, antibiotics, specialty chemicals and other molecules of value. Desired proteins may include but are not limited to monoclonal antibodies, enzymes and other recombinant antibodies, enzymes, peptides, virus. Even marginal improvements in yield and productivity increase profitability. Therefore, there are incentives to improve batch, fed-batch, or concentrated fed-batch reactor operations.
  • alternating tangential flow (ATF) filtration can be adapted to perform rapid harvesting from a cell culture, such as a fed-batch culture or a concentrated fed-batch culture, to achieve the beneficial result of rapid, high-yield harvesting of cell products.
  • ATF alternating tangential flow
  • the use of ATF for harvesting fed-batch and other types of cell cultures allows for a rapid harvest procedure carried out with minimal steps, because the new methods simplify the harvest procedure, which generally requires two or more steps such as centrifugation and depth filtration.
  • ATF harvesting results in a feed stream suitable for the next stage, e.g., a chromatography column, with high clarity and thus avoids fouling of downstream systems. Accordingly, the present disclosure describes a series of methods for harvesting fed-batch and concentrated fed-batch cultures using ATF.
  • centrifugation or depth filters it is common to use centrifugation or depth filters to harvest the protein from fed-batch bioreactors.
  • the recovery of protein using these common technologies is low, and is a time consuming process.
  • the use of ATF as rapid harvesting equipment on a fed-batch bioreactor can reduce the harvesting time to less than 8 or 10 hours.
  • the new methods also maintain the protein quality, because the cell viability remains high through the entire process of harvesting.
  • the present disclosure includes methods of harvesting a cell product from a cell culture, e.g., a fed-batch or concentrated fed-batch cell culture.
  • Cell products include any desired endogenous and recombinant proteins, nucleic acids, viruses, and other molecules of value. Desired proteins may include, but are not limited to, monoclonal antibodies, enzymes, and other recombinant or naturally occurring proteins.
  • the methods include culturing cells in a starting volume of culture medium until the cells have produced a cell product at a harvest concentration in the culture medium, wherein the cells are cultured in a cell culture system including a bioreactor connected to an alternating tangential flow (ATF) device; draining culture medium from the bioreactor through the ATF device until the culture medium volume reaches a predetermined volume, wherein the ATF device provides at an ATF outlet a liquid containing cell product and returns to the bioreactor culture medium with a concentration of cell product that is lower than the harvest concentration; extracting the liquid containing cell product from the ATF outlet; refilling the bioreactor with a fluid medium to a volume that is equal to, higher than, or lower than the starting volume; and repeating one or more of the draining, extracting, and refilling steps until a desired amount of cell product has been removed from the bioreactor.
  • ATF alternating tangential flow
  • the predetermined volume can be lower or higher than the starting volume, or about the same as the starting volume.
  • the fluid medium used to refill the bioreactor can be phosphate buffered saline (PBS), or cell culture medium, or any other liquid that can be used to maintain the cells alive.
  • the refilling includes simultaneously refilling the bioreactor at a rate equal to the rate of draining of the culture medium from the bioreactor or at a rate of extracting the liquid from the ATF outlet.
  • the draining step and the refilling step are performed sequentially, and/or the refilling step and draining step are performed two or more times.
  • the harvest can takes less than 18 hours, e.g., less than 24, 20, 18, 16, 14, 12, 10 hours, or less, e.g., less than 9, 8, 7.5, 7.0, 6.5, 6.0, 5.5, or 5.0 hours, or less, for a volume between 500 liters and 2000 liters.
  • repeating both the draining step until the bioreactor volume reaches a predetermined volume and the extracting step can take less than 2.5 hours.
  • the culture medium is drained at a filter flux of about 2 to 30 liters/meter 2 /hour (LMH), e.g., about 2, 4, 5, 6, 7, 8, 9, or 10 to 30 liters/meter2/hour (LMH), e.g., 3 to 25, 4 to 20, or 5 to 15 LMH.
  • LMH liters/meter 2 /hour
  • LMH liters/meter2/hour
  • the predetermined volume can be about 5% to about 30% of the starting volume or about 10% to about 20% of the starting volume.
  • the cell culture can be a concentrated fed-batch culture, and the predetermined volume can be about 50% of the starting volume or 100% of the starting volume.
  • the predetermined volume is determined based on a cell concentration in the culture medium.
  • the ATF device can include a hollow fiber filter, e.g., having a pore size of about 0.1 to 5.0 microns, e.g., 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, or 0.9 microns, or 1, 2, 3, or 4 microns, or about 500 to 1000 kD, e.g., 550, 600, 650, 700, 750, 800, 850, 900, or 950 kD.
  • a hollow fiber filter e.g., having a pore size of about 0.1 to 5.0 microns, e.g., 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, or 0.9 microns, or 1, 2, 3, or 4 microns, or about 500 to 1000 kD, e.g., 550, 600, 650, 700, 750, 800, 850, 900, or 950 kD.
  • any two or more of the draining step, the extracting step, and the refilling step can occur simultaneously and at a first flow rate.
  • any one or more of the draining step, the extracting step, and the refilling step can be started before the cells have produced all of the cell product to be harvested at the conclusion of cell culture process.
  • the draining step, the extracting step, and the refilling step are started 1 to 8 days, e.g., 2 to 7 days or 3 to 6 days, before the cells have produced the cell product at the harvest concentration in the fluid medium.
  • the extracting and refilling volume are less than about 1.0, e.g., less than about 0.9, 0.8, 0.7, 0.6, 0.5, 0.4, 0.3, 0.2, or 0.1 vessel volume exchanged per day (VVD).
  • a final harvesting step is conducted at a second flow rate different from the first flow rate.
  • a final draining step can result in less than about 20%, e.g., less than 10%, of the starting volume remaining in the bioreactor.
  • the cell culture can be a fed-batch cell culture or a concentrated fed-batch cell culture, and the methods can be used to produce cell products such as monoclonal antibodies, enzymes, and/or viruses.
  • the disclosure provides systems for harvesting a cell product from a cell culture.
  • These systems include a bioreactor including an inlet and an outlet; a source of cell culture medium containing no cell product connected to the bioreactor inlet; an alternating tangential flow (ATF) device connected to the bioreactor outlet; a pump connected to an outlet from the ATF device and configured to remove fluid from the ATF device; and a controller arranged and programed to carry out one or more of the methods described herein, either singly or in various combinations and subcombinations.
  • ATF alternating tangential flow
  • the methods and systems described in this disclosure provide several advantages, including maintaining high cell viability and better protein quality in the products harvested using the new methods described herein, because of low shear during harvest of fed-batch cultures.
  • Cell death or stress often leads to release of protein degrading or modifying enzymes, which can compromise product quality.
  • the new methods and systems result in higher yields and increased productivity with improved protein quality.
  • the new methods and systems allow recovery of the cell broth with the cells largely intact and in an unadulterated form and do not impair the subsequent separation performance of or increase risk of increasing unwanted biologics during the harvest of and separation of the cultured cells from their liquid media.
  • the rate of protein passage through the membrane is important to complete the separation step quickly. Production time using the new methods and systems represents an economic advantage and also can be required to obtain unstable proteins quickly to avoid unwanted product modifications such as degradation.
  • “Fed-batch culture” refers to an operational technique for biotechnological processes where one or more nutrients necessary for cell growth and product formation are fed or supplied to the bioreactor during cultivation either intermittently or continuously via one or more feed streams during the course of an otherwise batch operation. There are no effluent streams during the course of operation, so the bioreactor products remain in the bioreactor until the end of the run when they are harvested. This process may be repeated a number of times if the cells are fully viable and productive.
  • Fed-batch cultures are advantageous since the fed-batch operation can provide unique means of regulating the concentration of compounds that control the key reaction rates and, therefore, can provide a definite advantage over the batch operation through the manipulation of one or more feed rates.
  • Fed-batch culture is also advantageous for large-scale production due to its operational simplicity and familiarity as a carryover process from fermentation.
  • depth filtration refers to filtration that uses a porous filtration medium to retain particles throughout the medium, rather than just on the surface of the medium. Such filters are commonly used when the fluid to be filtered contains a high load of particles as, they can retain a large mass of particles before becoming clogged compared to other types of filters. Depth filtration is typified by multiple porous layers whose depth are used to capture solid contaminants from the liquid phase.
  • diafiltration refers to a dilution process that involves removal or separation of components (e.g., permeable molecules like salts, small proteins, solvents etc.,) of a solution based on their molecular size by using micro-molecule permeable filters in order to produce pure solution. This is often performed by removing filter permeate at the same rate as adding liquid to the solution being filtered (termed constant volume diafiltration).
  • components e.g., permeable molecules like salts, small proteins, solvents etc.
  • cell broth refers to the liquid in which the cells are suspended during culture. In a fed-batch process this includes both the fed media and nutrients, as well as the cell products (e.g., proteins and waste).
  • CFB concentrated fed-batch
  • ATF Alternating Tangential Flow
  • Tangential Flow Filtration TNF
  • ultrafiltration membrane e.g., 50 kDa or 30 kDa nominal MW cutoff
  • continuous feeding refers to the continuous addition of media or media components to the bioreactor for some portion of the harvest period.
  • FIG. 1 is schematic of an apparatus and process for performing rapid ATF fed-batch harvest.
  • FIG. 2 is a flow chart of a method for performing the rapid ATF fed-batch harvest of FIG. 1 .
  • FIG. 3 is a plot of viable cell density (VCD) and viability as a function of culture time using the method of FIG. 1 .
  • FIG. 4 is a plot of protein concentration as a function of culture time using the method of FIG. 1 .
  • FIG. 5 is a plot of cell-specific productivity based on cumulative protein as a function of the integral of viable cell count (IVC) using the method of FIG. 1 .
  • FIG. 6 is an overall system diagram for performing rapid ATF fed-batch harvest.
  • FIG. 7 is schematic of an apparatus and process for performing rapid ATF fed-batch harvest with continuous diafiltration.
  • FIG. 8 is a flow chart of a method for performing the rapid ATF fed-batch harvest of FIG. 7 .
  • FIG. 9 is a plot of viable cell density and viability as a function of culture time using the method of FIG. 7 .
  • FIG. 10 is a plot of protein concentration as a function of culture time using the method of FIG. 7 .
  • FIG. 11 is a plot of cell-specific productivity based on cumulative protein as a function of the integral of viable cell count using the method of FIG. 7 .
  • FIG. 12 is a schematic of an embodiment and an apparatus and process for performing rapid ATF concentrated fed-batch harvest with continuous diafiltration.
  • FIG. 13 is a schematic of an embodiment of an apparatus and process for performing rapid ATF concentrated fed-batch harvest with continuous diafiltration.
  • FIG. 14 is a schematic of an embodiment of an apparatus and process for performing rapid ATF fed-batch harvest with continuous feeding followed by rapid harvest.
  • FIG. 15 is a plot of viable cell density and viability as a function of culture time using the method of FIG. 14 compared to traditional fed-batch processes.
  • FIG. 16 is a plot of cell-specific productivity based on cumulative protein as a function of the integral of viable cell count using the method of FIG. 14 compared to traditional fed-batch processes.
  • FIG. 17 is a plot of protein concentration as a function of culture time using the method of FIG. 14 compared to traditional fed-batch processes.
  • FIG. 18 is a schematic of an embodiment of an apparatus and process for performing ATF rapid harvest using continuous feeding with an ultra-filter.
  • the present disclosure describes the use of alternating tangential flow (ATF) filtration for performing fed-batch harvesting.
  • ATF alternating tangential flow
  • the use of ATF for harvesting fed-batch cultures allows for a rapid harvest procedure carried out in a single process step, processing a batch with a single set of equipment with a single product as a processed material.
  • These methods are successful when using ATF, compared to other tangential flow filtration methods due to the ability to perform product harvesting at a higher filter flux with ATF.
  • Alternating tangential flow has been used to perform filtration and separate cells from product in a single step, but is normally limited to a filter flux of 1.3-5.7 LMH, which is too slow to be useful in a commercial culture harvest setting.
  • ATF filtration was performed at a higher flux (e.g., greater than 10 LMH) as described herein, the filter did not foul and a rapid recovery of product from a culture was obtained in a short processing time.
  • This rapid harvest of a culture with ATF has utility in commercial processes as an economically advantageous way to obtain a clarified feed stream suitable for further processing in a single step.
  • the new methods also simplify the harvest procedure, which heretofore has generally required two or more steps such as centrifugation followed by depth filtration.
  • ATF harvesting as described herein results in a feed stream that can be used directly in the next stage, e.g., to a chromatography column, with high clarity and thus avoids downstream fouling, e.g., of the chromatography column, without the need for any other filtration or other clarification step.
  • biotechnological processes are leveraged to create a desired product.
  • one or more nutrients necessary for cell growth and product this may include, for example, any desired cellular product including endogenous and recombinant products including proteins, nucleic acids, virus, and other molecules of value, formation are fed or supplied to the bioreactor during cultivation.
  • This feeding is performed either continuously or intermittently via one or more feed streams during the course of an operation. There are no effluent streams during the course of operation, so the volume of liquid and cells within the bioreactor increases during the operation.
  • the bioreactor products remain in the bioreactor until the end of the run when they are harvested, typically after 5 to 30 days, e.g., 7 to 25, or 10 to 21 days of culture.
  • Harvesting of fed batch cultures is best performed with little damage to cells in the broth, rapidly to provide efficient processing without product modification and with clarification needed for further processing of a product by chromatography.
  • ATF is uniquely able to support these requirements.
  • ATF has been used in perfusion culture systems in which cell media is continually supplied to the bioreactor containing the cells and the ATF continually filters the culture, removing culture waste materials and protein product using a microfiltration membrane.
  • This process allows protein to be harvested continuously or at frequent intermittent intervals, and at low filter flux (1.3-5.7 LMH) for the cultivation period that lasts 30 days or even longer. This process is carried out at high cell densities (e.g., 50-150E6 cells/mL or higher).
  • These ATF assisted perfusion cultures can also be performed with an ATF containing an ultrafilter (e.g., nominal pore size 50 kD or smaller) during which waste materials are removed but the product is retained within the culture broth. These cultures are operated at a low filter flux.
  • CFB concentrated fed batch
  • the ATF process is instead adapted to serve as rapid harvesting equipment (replacing depth filtration and centrifugation) on a fed-batch culture.
  • ATF is used differently with a high filter flux on the day of harvesting the fed-batch culture, with cell densities that usually range from 7-20E6 cells/ml or a CFB culture with cell densities ranging from 50-200E6 cells/ml (e.g., between 75-120E6 cells/ml).
  • the product e.g., protein
  • the use of an ATF system as rapid harvesting equipment on a fed-batch or CFB bioreactor can overcome the aforementioned issues as this entire harvesting process maintains high cell viability and better product quality.
  • the methods are embodied in four different rapid harvesting techniques for fed-batch and concentrated fed-batch bioreactors that include:
  • An ATF system with a hollow fiber porous membrane (e.g., microfiltration pore sizes such as 0.1-5.0 micron or ultrafiltration membranes such as 750 kDa MWCO) is well suited for harvesting a fed-batch culture because it retains cells and also other small particulates, which are necessary to remove before downstream processes.
  • Using ATF also reduces cross-contamination as the harvesting can be carried out in a sterile manner, unlike centrifugation or depth filtration.
  • an ATF harvest bioreactor system 200 includes a bioreactor 210 , which can be, for example, a stirred tank reactor.
  • the bioreactor 210 is connected via a drain tube 212 to an ATF 220 .
  • the ATF is a system such as ones used to perfuse a bioreactor culture using hollow fiber filtration using alternating tangential flow.
  • the ATF 220 includes a device that controls a diaphragm pump 222 to perform ATF through a hollow fiber filter 224 (see, e.g., U.S. Pat. No. 6,544,424) both of which are encased in a sterilizable housing 226 .
  • Medium and additives are introduced into the bioreactor 210 via a feed line 214 , which is controlled by a valve and/or pump 216 .
  • An air supply source and the controller 240 ( FIG. 6 ) are connected to the diaphragm pump 222 via an air tube 228 . Air is added and withdrawn from the diaphragm pump 222 so as to increase and decrease the volume of the two chambers contained within the diaphragm pump, altering the pressure within the housing 226 and directing flow of the fluid contained within the housing 226 and drawing fluid across the membrane of the hollow fiber filter 224 .
  • the interior portion of the hollow fibers is fluidly connected to the bioreactor via drain tube 212 while the chamber outside the hollow fibers of the hollow fiber filter 224 and within the housing 226 is fluidly connected to a product drain tube 230 .
  • the product drain tube 230 has a harvest pump/valve 232 that controls withdrawal of the products that filter across the hollow fiber filter and reside in the chamber between the hollow fiber filter 224 and housing 226 .
  • the product drain tube 230 is shown near the top of the ATF 220 , however the product drain tube 230 could also be located near the middle or bottom of the ATF 220 .
  • the product e.g., the protein
  • LMH liters/meter 2 /hour
  • the rapid harvest can be accomplished by cyclical removal of volume from the culture vessel and refilling (batch filtration) or by continually replenishing the liquid in the culture broth while harvesting liquid through the filtration process (constant volume diafiltration). Both approaches are described below and in the specific examples. It is practical in most bioreactor designs to only be able to remove approximately 80% of the volume and still maintain adequate stirring thus while some reactors may allow greater than 80% most generally, removal of 80% or less in the batchwise or cyclical method of filtration will be described.
  • the 15 LMH flux results in a drain time of approximately 2.1 to 2.5 hours in the present methods (assuming an ATF filter size of 11 m 2 ).
  • This draining of the protein continues until the remaining volume in the bioreactor 210 volume drops down to, for example, 30% although other volume decrease values can be used (e.g., 20%).
  • the harvest pump 232 is paused.
  • the cells all remain in the bioreactor 210 and are within a media broth that is then filled to approximately the same amount of fluid as at the initiation of the harvest. In some instances, the media broth is then filled to a lower amount or a greater amount of fluid as the initiation of the harvest.
  • the fluid could be sterile phosphate buffered saline (PBS) or culture media or other fluid compatible with a viable cell broth.
  • PBS sterile phosphate buffered saline
  • the harvesting drain process resumes at flux of approximately 15 LMH until the volume in the bioreactor 210 again drops to approximately 30%. This cycle is repeated a third and fourth time, if desired or required. Approximately 96% of protein from the fed-batch culture originally contained within the bioreactor 210 is recovered and cell viability maintained.
  • step 150 When the fed-batch culture has completed, harvest starts at step 150 .
  • the harvest is carried out using ATF to drain the cell broth at a flux between 10-30 LMH (e.g., 15 LMH) until the volume of the bioreactor 110 is reduced to 10-50% or more preferably 20-30% of its initial volume, step 160 .
  • the harvest pump 232 is paused, and the operator determines whether the desired recovery has been achieved at step 170 . This can be measured by number of drain/refill cycles (e.g., 2 or 3) or other means such as assaying the total amount or concentration of the harvested product. If the harvest is to continue, the bioreactor 210 is refilled at step 180 , returning to the drain step 160 and ultimately to harvest completion at step 190 .
  • a rapid ATF harvest procedure using continuous diafiltration is shown in FIG. 7 .
  • This method of constant volume diafiltration provides a higher yield with less volume than the batchwise method. Testing for both methods for yield and time could be carried out to choose the best method for a given application.
  • the components for harvesting with ATF continuous diafiltration are similar to those shown in FIG. 1 .
  • the ATF harvest bioreactor system 300 includes a bioreactor 310 connected via a drain tube 312 to an ATF 320 .
  • the ATF 320 includes a device that controls a diaphragm pump 322 to perform ATF through a hollow fiber filter 324 both of which are encased in a sterilizable housing 326 .
  • Medium and additives are introduced to the bioreactor 310 via a feed line 314 , which is controlled by a valve and/or pump 316 .
  • An air supply source and controller (not shown) are fluidly connected to the diaphragm pump 322 via an air tube 328 .
  • the interior portion of the hollow fibers (retentate) is connected to the bioreactor 310 via drain tube 312 while the chamber outside the hollow fibers of the hollow fiber filter 324 and within the housing 326 is connected to a product drain tube 330 (permeate).
  • the product drain tube 330 has a harvest pump/valve 332 which controls withdrawal of the products within the permeate.
  • the protein is also harvested using the ATF 320 at a flux of 10-30 LMH (generally 12-18 or 15 LMH) until the volume of the bioreactor 310 drops down to a volume in which the elevated flux can be maintained for up to 4 bioreactor volumes of fluid transfer by filtration.
  • the percentage of volume reduction may be 0-100%, for example, 30% for fed batch cultures or 0-50% for CFB cultures. In some instances, the percentage of volume reduction is, for example, 10-90%, e.g., 25-75%, e.g., 30-60%, e.g., 5, 10, 15, 20, 25, 30, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, or 100%.
  • the 15 LMH flux through an 11 m 2 filter results in a drain time to the 30% level of approximately 2.1 hours.
  • a diafiltration process is started to maintain the bioreactor volume by either addition of PBS or culture media (or other fluid compatible with maintaining cell viability) via the feed line 314 at flow rate equivalent to the fluid harvest rate via the product drain tube 330 (the permeate).
  • This diafiltration process can occur at a flux of, for example, 15 LMH until the yield of desired product in the permeate reaches greater than 90%. Rapid harvesting by this method is therefore completed in less than approximately 6-8 hours (e.g., less than 6 hours).
  • step 250 When the fed-batch culture has completed, harvest starts at step 250 .
  • the harvest is carried out using ATF to drain the cell broth at a flux of from 10-30 LMH (e.g., 15 LMH) until the volume of the bioreactor 310 is approximately 30% its initial volume, step 260 .
  • the flow rate of the harvest pump 332 is reduced while fluid is added to the bioreactor 210 via the feed line 214 at approximately the same rate (e.g., 15 LMH) to complete a diafiltration cycle, step 270 .
  • step 280 Once a diafiltration cycle is complete by cycling through an entire displaced volume it is decided (at step 280 ) if the harvest is to continue (e.g., not yet 90% or 96% recovery) and the system returns to step 270 to perform an additional diafiltration cycle. Once the desired volume has been achieved the harvest operation is completed at step 290 .
  • FIG. 12 a rapid ATF harvest procedure using continuous diafiltration for concentrated fed-batch systems is shown in FIG. 12 .
  • the process of ATF rapid harvest for concentrated fed-batch (CFB) depends on viable cell density on the day of harvest.
  • the components for harvesting with ATF continuous diafiltration are similar to those shown in FIG. 1 .
  • an ATF harvest bioreactor system 400 includes a bioreactor 410 , which can be, for example, a stirred tank reactor.
  • the bioreactor 410 is connected via a drain tube 412 to an ATF 420 .
  • the ATF is a system such as ones used to perfuse a bioreactor culture using hollow fiber filtration using alternating tangential flow.
  • the ATF 420 includes a device that controls a diaphragm pump 422 to perform ATF through a hollow fiber filter 424 (see, e.g., U.S. Pat. No. 6,544,424) both of which are encased in a sterilizable housing 426 .
  • Medium and additives are introduced into the bioreactor 410 via a feed line 414 , which is controlled by a valve and/or pump 416 .
  • An air supply source and controller (not shown) are fluidly connected to the diaphragm pump 422 via an air tube 428 . Air is added and withdrawn from the diaphragm pump 422 so as to increase and decrease the volume of the two chambers contained within the diaphragm pump, altering the pressure within the housing 426 and directing flow of the fluid contained within the housing 426 and drawing fluid across the membrane of the hollow fiber filter 424 .
  • the interior portion of the hollow fibers is fluidly connected to the bioreactor via drain tube 412 while the chamber outside the hollow fibers of the hollow fiber filter 424 and within the housing 426 is fluidly connected to a product drain tube 430 .
  • the product drain tube 430 has a harvest pump/valve 432 that controls withdrawal of the products that filter across the hollow fiber filter and reside in the chamber between the hollow fiber filter 424 and housing 426 .
  • the product drain tube 430 is shown near the top of the ATF 420 , however the product drain tube 430 could also be located near the middle or bottom of the ATF 420 . Alternatively, there may be more than one product drain tube 430 connected to the housing 426 .
  • the protein is harvested using the ATF 420 at a flux of 10-30 LMH (generally 12-18, 13-16, or 15 LMH) until the volume of the bioreactor 410 drops down to a volume in which the elevated flux can be maintained for up to 4 bioreactor volumes of fluid transfer by filtration. This may be 0-50%, for example 50%, depending on the cell density.
  • a continuous diafiltration process is started to maintain the bioreactor volume by either addition of PBS or culture media (or other fluid compatible with maintaining cell viability) via the feed line 414 at flow rate equivalent to the fluid harvest rate via the product drain tube 430 (the permeate).
  • This diafiltration process can occur at a flux of, for example, 10-30 LMH until the yield of desired product in the permeate reaches greater than 90%. Rapid harvesting by this method is therefore completed in less than approximately 6-8 hours (e.g., less than 6 hours).
  • a continuous diafiltration process is started to maintain the bioreactor volume at 100% by either addition of PBS or culture media (or other fluid compatible with maintaining cell viability) via the feed line 414 at flow rate equivalent to the fluid harvest rate via the product drain tube 430 .
  • This diafiltration process can occur at a flux of, for example, 10-30 LMH until the yield of desired product in the permeate reaches greater than 90%, e.g., after 4 bioreactor volume exchanges. After 4 volume exchanges the remaining media will be harvested in exchange with either PBS or fresh media.
  • Table 1 shows a suggested reduction in bioreactor volume depending on the cell density on the day of harvest (which can be determined by known measurement techniques).
  • a fed-batch with continuous feeding and rapid harvest process was developed to further shorten the harvesting time. This technique both shortens the harvest time by half and increases protein production while maintaining cell viability to assure high product quality. Increased protein production during harvest is not achievable by currently existing commercially available fed-batch harvest techniques. The increased productivity is especially advantageous since it is accomplished without a change in basic equipment used in fed batch culturing such as the bioreactor or control systems for cell culture.
  • Continuous slow feeding of a fed-batch bioreactor during the final days of cultivation boosts the protein production without adding additional time to the fed-batch cultivation and harvest processes. This can be accomplished using either a microfilter (collection of the product in the permeate) or with an ultrafilter (retention of the product in the reactor where it will be collected during the final harvest stage). Moreover, the continuous harvest process also increases the viability of a fed-batch culture, which is favorable to protein quality. This process reduces cross contamination as the entire process is conducted in a sterile manner, unlike centrifugation or depth filtration.
  • FIG. 14 shows a schematic for the apparatus for use with the fed-batch with continuous feeding & rapid harvest using ATF method.
  • the components for harvesting with ATF continuous diafiltration are similar to those shown in FIG. 1 .
  • an ATF harvest bioreactor system 500 includes a bioreactor 510 , which can be a stirred tank reactor.
  • the bioreactor 510 is connected via a drain tube 512 to an ATF 520 .
  • the ATF 520 includes a device that controls a diaphragm pump 522 to perform ATF through a hollow fiber filter 524 both of which are encased in a sterilizable housing 526 .
  • Medium and additives are introduced into the bioreactor 510 via a feed line 514 , which is controlled by a valve and/or pump 516 .
  • An air supply source and controller are fluidly connected to the diaphragm pump 522 via an air tube 528 .
  • Air is added and withdrawn from the diaphragm pump 522 so as to increase and decrease the volume of the two chambers contained within the diaphragm pump, altering the pressure within the housing 526 and directing flow of the fluid contained within the housing 526 and drawing fluid across the membrane of the hollow fiber filter 524 .
  • the interior portion of the hollow fibers is fluidly connected to the bioreactor via drain tube 512 while the chamber outside the hollow fibers of the hollow fiber filter 524 and within the housing 526 is fluidly connected to a product drain tube 530 .
  • the product drain tube 530 has a harvest pump/valve 532 that controls withdrawal of the products that filter across the hollow fiber filter and reside in the chamber between the hollow fiber filter 524 and housing 526 .
  • Continuous feeding can take place in low volume (less than 1.0 vessel volume exchanged per day (VVD), e.g., less than 0.7 VVD), and for a variable number of days (for example 2-8 days) prior to performing the rapid harvest.
  • VVD vessel volume exchanged per day
  • a continuous slow feeding and harvesting (@ 0.5 VVD) takes place from day 11 to day 14 of cultivation.
  • simultaneous feeding and harvesting as rapid harvest occurs.
  • the protein is harvested using the ATF 520 at a flux of 10-30 LMH (generally 12-18, 13-16, or 15 LMH) until the volume of the bioreactor 510 drops down below 20% (preferably ⁇ 10%), substantially harvesting the liquid portion of the bioreactor.
  • the rapid harvest part of the process takes approximately 3 hours to complete for the size bioreactor shown.
  • the continuous feeding and rapid harvest process has significant advantages.
  • the methods described earlier in this disclosure require 14 days culture and approximately 6 hours of additional harvest time, resulting in final amount of recovered protein.
  • In the continuous feeding and rapid harvest process using ATF there are 11 days of regular culture followed by 3 days continuous feed/harvest (for the same total of 14 days) follow by only 3 hours of rapid harvest.
  • This process results in an increased amount of protein recovered in substantially the same amount of time from the same bioreactor equipment used in fed batch culture production.
  • the continuous feed during low volume harvest prior to rapid harvest maintains or improves cell viability and product quality better than currently available process technology.
  • the final product pool can further be concentrated by use of the ATF with an ultrafilter to reduce volume for subsequent additional processing or storage of the product.
  • a variety of testing and experimental procedures were required to improve a fed-batch rapid harvesting system with use of ATF step-diafiltration. Examples include a 6 L fed-batch bioreactor (with an ATF2 system from Repligen Corp., Waltham Mass.) for rapid harvesting. ATF2 data was used to extrapolate to a 1000 L fed-batch bioreactor (with an ATF10 system from Repligen Corp., Waltham Mass., a commercially available perfusion product for 500 L and 1000 L bioreactors).
  • LONG®R3IGF-1 adapted CHO DP12 cells was thawed and grown in 125 mL shake flask (working volume 40 mL) containing CD OptiCHO® medium with 100 ng/mL LONG®R3IGF-1, 200 nM Methotrexate and 4 mM Glutamax®. After 4-6 days, the cells were passaged/sub cultured again into a 1 L (working volume 200 mL) shake flask in order to generate sufficient number of cells to be inoculated into the bioreactor.
  • Bioreactor Conditions Mode Set point Controlled by Temperature AUTO 37° C. Heating Blanket Agitation AUTO 280 rpm Stirrer pH AUTO 6.8-7.2 CO 2 and DO AUTO 40% O 2 supplement Air Manual 500 mL/min Constant
  • FIG. 3 shows the resulting plot of viable cell density (VCD) and viability as a function of culture time. These are typical profiles in fed-batch cultures and generally the viability on the day of harvest varies between 60-85%.
  • the maximum VCD was ⁇ 14 E6 cells/mL and the VCD at the day of harvest was 9-10E6 cells/mL.
  • FIG. 4 is a plot of concentration of protein in fed-batch culture from day 1 through day 14. The final concertation of protein on the day of harvest was ⁇ 600 mg/L and this was used as an initial concertation before starting the rapid harvest process.
  • FIG. 5 is a plot of cell-specific productivity or cumulative protein as a function of cell growth over time, i.e., the integral of viable cells (IVC).
  • IVC integral of viable cells
  • ATF step-diafiltration the entire process can be combined to a single step with shorter duration.
  • ATF with 0.2 ⁇ m micro filter is well suited for harvesting a fed batch culture because it retains cells and also other small particulates, which are beneficial for downstream processes.
  • Using ATF also reduces cross contamination as the harvesting can be conducted in a sterile manner.
  • the commercially available ATF10 system can provide ATF perfusion for 500 L and 1000 L bioreactors, and can be used in multiples to easily scale up to 2000 L bioreactors. Based on the data described herein, protein recoveries can be over 95% using rapid harvest using step-diafiltration.
  • the overall time for harvesting process using ATF step-diafiltration is less than 8 hours. No significant drop in viability indicates that protein quality does not alter during harvesting process.
  • Each ATF10 has 11 m 2 surface area and when they are used simultaneously the total combined area is 22 m 2 .
  • the total harvesting time can be further shortened by increasing the number of ATF10 devices from 2 to 3 or more.
  • ATF2 with a 6 L fed-batch bioreactor at a flux of 15 LMH was successfully demonstrated to harvest protein in less than 8 hours with recovery of 96% of the product.
  • Extrapolating the surface area from ATF2 (0.13 m 2 ) to ATF10 (11 m 2 ) allows one to predict that a 500 L fed-batch bioreactor can be rapidly harvested within 8 hours using an ATF10 according to the methods described herein.
  • a 1000 L fed-batch bioreactor can be harvested in 8 hours using two ATF10s (total filter surface area (SA): 22 m 2 ).
  • SA total filter surface area
  • a 2 L fed-batch bioreactor connected to ATF2 was used to mimic a 6 L fed-batch bioreactor using a scale down model (SDM), recirculation approach.
  • a 6 L bioreactor with ATF2 data was used to extrapolate to 500 L and 1000 L fed-batch bioreactor using an ATF10.
  • FIG. 9 shows the resulting plot of viable cell density (VCD) and viability as a function of culture time. These are typical profiles in fed-batch cultures and generally the viability on the day of harvest varies between 60-85%.
  • the maximum VCD was ⁇ 14E6 cells/mL and the VCD at the day of harvest was 9-10E6 cells/mL.
  • FIG. 10 is a plot of protein or titer content is a plot of concentration of protein in fed-batch culture from day 1 through day 14. The final concertation of protein on the day of harvest was ⁇ 600 mg/L and this was used as an initial concertation before starting the rapid harvest process.
  • FIG. 11 is a plot of cell-specific productivity or cumulative protein as a function of cell growth over time, i.e., the integral of viable cells (IVC).
  • IVC integral of viable cells
  • ATF continuous-diafiltration the entire process can be combined to a single step with even shorter duration than the ATF step-diafiltration process.
  • ATF with 0.2 ⁇ m microfilter is well suited for harvesting a fed batch culture because it retains cells and also other small particulates, which if removed are beneficial for downstream processes.
  • Using ATF also reduces cross contamination as the harvesting can be demonstrated in a sterile manner.
  • the systems described herein can be scaled up to 500, 1000, 1500, or 2000 L, for example, using two or more ATF10 perfusion products (Repligen, Waltham Mass.). Based on the data described herein, the protein recoveries can be better than 95% using rapid harvest using step-diafiltration.
  • the overall time for harvesting process using ATF continuous diafiltration is less than 6 hours. No significant drop in viability indicates that protein quality does not alter during harvesting process.
  • ATF2 with a 6 L fed-batch bioreactor at a flux of 15 LMH was successfully demonstrated to harvest protein in less than 6 hours with recovery of 95%. Extrapolating the surface area from ATF2 (0.13 m 2 ) to ATF10 (11 m 2 ), allows one to predict that a 500 L fed-batch bioreactor can be rapidly harvested within 6 hours using an ATF10. Similarly, a 1000 L fed-batch bioreactor can be harvested in 6 hours using two ATF10s. In addition, there was no significant loss of viability during harvesting process.
  • the FB with continuous feeding and rapid harvest process was developed to further shorten the harvesting time by half and increase protein production. This is achieved through a low volume continuous feed prior to rapid harvest together with a high flux rapid harvest. In the example described below a 40% increase in protein yield was obtained compared to currently existing commercially available fed-batch harvest techniques.
  • continuous feeding and rapid harvest process using ATF there are 11 days of regular culture as described in other examples, followed by 3 days continuous feed/harvest (for the same total of 14 days) follow by only 3 hours of rapid harvest.
  • Other embodiments could change the length of time for the continuous feed or the volume of the continuous feed to obtain similar improvements in cell viability and total protein production. For these tests a 2 L bioreactor with recirculation method was used to mimic 6 L fed-batch bioreactor, and flux was maintained at 15 LMH using recirculation approach.
  • FIG. 15 shows the resulting plot of viable cell density (VCD) and viability as a function of culture time for both continuous feeding and traditional fed-batch. Both VCD and viability showed increasing trends following the onset of continuous feeding and harvest on day 11.
  • FIG. 16 is a plot of cell-specific productivity or cumulative protein as a function of cell growth over time, i.e., the integral of viable cells (IVC) for both processes.
  • FIG. 17 is a plot of protein in fed-batch culture from day 1 through day 14 showing increased total accumulation after continuous feeding and harvest started on day 11 compared to traditional fed-batch.
  • Table 11 shows the conditions used for the fed-batch harvest culture.
  • the continuous feeding and rapid harvest process showed significant advantages. For this example, 11 days of regular culture followed by 3 days continuous feed/harvest followed by only 3 hours of rapid harvest obtained 1.4 times the amount of protein recovered by a conventional fed batch process. A process that can retain higher cell viability and yield higher protein production than currently available technology is a significant and meaningful process improvement.
  • system 600 can carry out a process with continuous feeding while using the ATF equipped with an ultrafilter.
  • Other elements of system 600 are the same as in prior embodiments.
  • the product is retained in the bioreactor and all product is harvested during the rapid harvest phase. This further reduces the volume of the final product pool while still obtaining the increase product yield.

Landscapes

  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Sustainable Development (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Water Supply & Treatment (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Computer Hardware Design (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Cyclones (AREA)
  • Catching Or Destruction (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Methods and systems of harvesting a cell product from a cell culture by culturing cells in a fluid medium until the cells have produced a cell product at a harvest concentration are disclosed. The cells are cultured in a cell culture system including a bioreactor connected to an ATF device. The methods include draining fluid medium from the bioreactor through the outlet and the ATF device until the bioreactor volume reaches a predetermined volume, and the ATF column yields at an ATF outlet a liquid containing cell product and passes fluid medium with a concentration of cell product that is lower than the harvest concentration back into the bioreactor, extracting the liquid containing cell product from the ATF outlet, refilling the bioreactor with sterile phosphate buffered saline or fluid medium without any cell product, and repeating steps until a desired amount of cell product has been removed.

Description

    CROSS-REFERENCE TO RELATED APPLICATION
  • This application is a continuation of U.S. Ser. No. 15/659,562, filed Jul. 25, 2017, which claims benefit under 35 U.S.C. § 119(e) to U.S. Ser. No. 62/366,557, filed on Jul. 25, 2016, of which entire contents of each are incorporated herein by reference.
  • FIELD OF THE INVENTION
  • The invention relates to the use of alternating tangential flow filtration units for harvesting products from bioreactors, e.g., for harvesting of products from fed-batch bioreactor cultures.
  • BACKGROUND
  • Cultures of microbial, plant, or animal cells are used to produce biological and chemical substances of significant commercial value. Particularly for commercial production, these cultures can be run in three operational modes: batch, continuous, fed-batch, or concentrated fed-batch. Applications include fermentation, biotechnology, and chemical, for production of specialty chemicals and products, as well as waste-treatment. The products are typically high-value products that include any desired cellular products, such as endogenous and recombinant products, including proteins, peptides, nucleic acids, virus, amino acids, antibiotics, specialty chemicals and other molecules of value. Desired proteins may include but are not limited to monoclonal antibodies, enzymes and other recombinant antibodies, enzymes, peptides, virus. Even marginal improvements in yield and productivity increase profitability. Therefore, there are incentives to improve batch, fed-batch, or concentrated fed-batch reactor operations.
  • Harvesting the products from a fed-batch bioreactor using current technology typically employs separation processes such as centrifugation and depth filtration, which can be time consuming and can generate lower product recovery than is desirable. Centrifugation has been part of cell harvesting for some time, but this process causes high shear, leading to low viability and potentially altered protein quality. Depth filtration has advantages over centrifugation, but has its own limitations such as the need for monitoring differential pressure, disposal of filters, large footprints, and scale-up issues. In addition, both centrifugation and depth filtration suffer from requiring a second clarification step to produce a fluid suitable for chromatographic separation processes.
  • SUMMARY
  • The methods and systems described in this disclosure are based, at least in part, on the discovery that alternating tangential flow (ATF) filtration can be adapted to perform rapid harvesting from a cell culture, such as a fed-batch culture or a concentrated fed-batch culture, to achieve the beneficial result of rapid, high-yield harvesting of cell products. The use of ATF for harvesting fed-batch and other types of cell cultures allows for a rapid harvest procedure carried out with minimal steps, because the new methods simplify the harvest procedure, which generally requires two or more steps such as centrifugation and depth filtration. ATF harvesting results in a feed stream suitable for the next stage, e.g., a chromatography column, with high clarity and thus avoids fouling of downstream systems. Accordingly, the present disclosure describes a series of methods for harvesting fed-batch and concentrated fed-batch cultures using ATF.
  • It is common to use centrifugation or depth filters to harvest the protein from fed-batch bioreactors. However, the recovery of protein using these common technologies is low, and is a time consuming process. According to the new methods and systems described herein, the use of ATF as rapid harvesting equipment on a fed-batch bioreactor can reduce the harvesting time to less than 8 or 10 hours. The new methods also maintain the protein quality, because the cell viability remains high through the entire process of harvesting.
  • In a first aspect, the present disclosure includes methods of harvesting a cell product from a cell culture, e.g., a fed-batch or concentrated fed-batch cell culture. Cell products include any desired endogenous and recombinant proteins, nucleic acids, viruses, and other molecules of value. Desired proteins may include, but are not limited to, monoclonal antibodies, enzymes, and other recombinant or naturally occurring proteins. The methods include culturing cells in a starting volume of culture medium until the cells have produced a cell product at a harvest concentration in the culture medium, wherein the cells are cultured in a cell culture system including a bioreactor connected to an alternating tangential flow (ATF) device; draining culture medium from the bioreactor through the ATF device until the culture medium volume reaches a predetermined volume, wherein the ATF device provides at an ATF outlet a liquid containing cell product and returns to the bioreactor culture medium with a concentration of cell product that is lower than the harvest concentration; extracting the liquid containing cell product from the ATF outlet; refilling the bioreactor with a fluid medium to a volume that is equal to, higher than, or lower than the starting volume; and repeating one or more of the draining, extracting, and refilling steps until a desired amount of cell product has been removed from the bioreactor.
  • In these methods, the predetermined volume can be lower or higher than the starting volume, or about the same as the starting volume. The fluid medium used to refill the bioreactor can be phosphate buffered saline (PBS), or cell culture medium, or any other liquid that can be used to maintain the cells alive.
  • In some implementations, the refilling includes simultaneously refilling the bioreactor at a rate equal to the rate of draining of the culture medium from the bioreactor or at a rate of extracting the liquid from the ATF outlet. In certain embodiments, the draining step and the refilling step are performed sequentially, and/or the refilling step and draining step are performed two or more times.
  • In the new methods, the harvest can takes less than 18 hours, e.g., less than 24, 20, 18, 16, 14, 12, 10 hours, or less, e.g., less than 9, 8, 7.5, 7.0, 6.5, 6.0, 5.5, or 5.0 hours, or less, for a volume between 500 liters and 2000 liters. For example, in some embodiments, repeating both the draining step until the bioreactor volume reaches a predetermined volume and the extracting step can take less than 2.5 hours. In certain embodiments, the culture medium is drained at a filter flux of about 2 to 30 liters/meter2/hour (LMH), e.g., about 2, 4, 5, 6, 7, 8, 9, or 10 to 30 liters/meter2/hour (LMH), e.g., 3 to 25, 4 to 20, or 5 to 15 LMH.
  • In various implementations, the predetermined volume can be about 5% to about 30% of the starting volume or about 10% to about 20% of the starting volume. In these methods, the cell culture can be a concentrated fed-batch culture, and the predetermined volume can be about 50% of the starting volume or 100% of the starting volume. In some embodiments, the predetermined volume is determined based on a cell concentration in the culture medium.
  • In some implementations, the ATF device can include a hollow fiber filter, e.g., having a pore size of about 0.1 to 5.0 microns, e.g., 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, or 0.9 microns, or 1, 2, 3, or 4 microns, or about 500 to 1000 kD, e.g., 550, 600, 650, 700, 750, 800, 850, 900, or 950 kD.
  • In these methods, any two or more of the draining step, the extracting step, and the refilling step can occur simultaneously and at a first flow rate. For example, any one or more of the draining step, the extracting step, and the refilling step can be started before the cells have produced all of the cell product to be harvested at the conclusion of cell culture process. In some embodiments, the draining step, the extracting step, and the refilling step are started 1 to 8 days, e.g., 2 to 7 days or 3 to 6 days, before the cells have produced the cell product at the harvest concentration in the fluid medium.
  • In some embodiments, the extracting and refilling volume are less than about 1.0, e.g., less than about 0.9, 0.8, 0.7, 0.6, 0.5, 0.4, 0.3, 0.2, or 0.1 vessel volume exchanged per day (VVD).
  • In some implementations, a final harvesting step is conducted at a second flow rate different from the first flow rate. In some embodiments, a final draining step can result in less than about 20%, e.g., less than 10%, of the starting volume remaining in the bioreactor.
  • In all of these methods, the cell culture can be a fed-batch cell culture or a concentrated fed-batch cell culture, and the methods can be used to produce cell products such as monoclonal antibodies, enzymes, and/or viruses.
  • In another aspect, the disclosure provides systems for harvesting a cell product from a cell culture. These systems include a bioreactor including an inlet and an outlet; a source of cell culture medium containing no cell product connected to the bioreactor inlet; an alternating tangential flow (ATF) device connected to the bioreactor outlet; a pump connected to an outlet from the ATF device and configured to remove fluid from the ATF device; and a controller arranged and programed to carry out one or more of the methods described herein, either singly or in various combinations and subcombinations.
  • The methods and systems described in this disclosure provide several advantages, including maintaining high cell viability and better protein quality in the products harvested using the new methods described herein, because of low shear during harvest of fed-batch cultures. Cell death or stress often leads to release of protein degrading or modifying enzymes, which can compromise product quality. The new methods and systems result in higher yields and increased productivity with improved protein quality. The new methods and systems allow recovery of the cell broth with the cells largely intact and in an unadulterated form and do not impair the subsequent separation performance of or increase risk of increasing unwanted biologics during the harvest of and separation of the cultured cells from their liquid media. The rate of protein passage through the membrane is important to complete the separation step quickly. Production time using the new methods and systems represents an economic advantage and also can be required to obtain unstable proteins quickly to avoid unwanted product modifications such as degradation.
  • “Fed-batch culture” refers to an operational technique for biotechnological processes where one or more nutrients necessary for cell growth and product formation are fed or supplied to the bioreactor during cultivation either intermittently or continuously via one or more feed streams during the course of an otherwise batch operation. There are no effluent streams during the course of operation, so the bioreactor products remain in the bioreactor until the end of the run when they are harvested. This process may be repeated a number of times if the cells are fully viable and productive. Fed-batch cultures are advantageous since the fed-batch operation can provide unique means of regulating the concentration of compounds that control the key reaction rates and, therefore, can provide a definite advantage over the batch operation through the manipulation of one or more feed rates. Fed-batch culture is also advantageous for large-scale production due to its operational simplicity and familiarity as a carryover process from fermentation.
  • The term “depth filtration” refers to filtration that uses a porous filtration medium to retain particles throughout the medium, rather than just on the surface of the medium. Such filters are commonly used when the fluid to be filtered contains a high load of particles as, they can retain a large mass of particles before becoming clogged compared to other types of filters. Depth filtration is typified by multiple porous layers whose depth are used to capture solid contaminants from the liquid phase.
  • The term “diafiltration” refers to a dilution process that involves removal or separation of components (e.g., permeable molecules like salts, small proteins, solvents etc.,) of a solution based on their molecular size by using micro-molecule permeable filters in order to produce pure solution. This is often performed by removing filter permeate at the same rate as adding liquid to the solution being filtered (termed constant volume diafiltration).
  • The term “cell broth” refers to the liquid in which the cells are suspended during culture. In a fed-batch process this includes both the fed media and nutrients, as well as the cell products (e.g., proteins and waste).
  • The term “concentrated fed-batch” (CFB), refers to use of a perfusion system (Alternating Tangential Flow (ATF)/Tangential Flow Filtration (TFF)) with an ultrafiltration membrane (e.g., 50 kDa or 30 kDa nominal MW cutoff) that retains the protein product in the bioreactor while removing waste products and feeding additional media into the reactor vessel. This process obtains higher cell concentration and retains product in the reactor like a conventional fed batch process.
  • The term “continuous feeding” refers to the continuous addition of media or media components to the bioreactor for some portion of the harvest period.
  • Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, suitable methods and materials are described below. All publications, patent applications, patents, and other references mentioned herein are incorporated by reference in their entirety. In case of conflict, the present specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and not intended to be limiting.
  • Other features and advantages of the invention will be apparent from the following detailed description, and from the claims.
  • DESCRIPTION OF DRAWINGS
  • FIG. 1 is schematic of an apparatus and process for performing rapid ATF fed-batch harvest.
  • FIG. 2 is a flow chart of a method for performing the rapid ATF fed-batch harvest of FIG. 1.
  • FIG. 3 is a plot of viable cell density (VCD) and viability as a function of culture time using the method of FIG. 1.
  • FIG. 4 is a plot of protein concentration as a function of culture time using the method of FIG. 1.
  • FIG. 5 is a plot of cell-specific productivity based on cumulative protein as a function of the integral of viable cell count (IVC) using the method of FIG. 1.
  • FIG. 6 is an overall system diagram for performing rapid ATF fed-batch harvest.
  • FIG. 7 is schematic of an apparatus and process for performing rapid ATF fed-batch harvest with continuous diafiltration.
  • FIG. 8 is a flow chart of a method for performing the rapid ATF fed-batch harvest of FIG. 7.
  • FIG. 9 is a plot of viable cell density and viability as a function of culture time using the method of FIG. 7.
  • FIG. 10 is a plot of protein concentration as a function of culture time using the method of FIG. 7.
  • FIG. 11 is a plot of cell-specific productivity based on cumulative protein as a function of the integral of viable cell count using the method of FIG. 7.
  • FIG. 12 is a schematic of an embodiment and an apparatus and process for performing rapid ATF concentrated fed-batch harvest with continuous diafiltration.
  • FIG. 13 is a schematic of an embodiment of an apparatus and process for performing rapid ATF concentrated fed-batch harvest with continuous diafiltration.
  • FIG. 14 is a schematic of an embodiment of an apparatus and process for performing rapid ATF fed-batch harvest with continuous feeding followed by rapid harvest.
  • FIG. 15 is a plot of viable cell density and viability as a function of culture time using the method of FIG. 14 compared to traditional fed-batch processes.
  • FIG. 16 is a plot of cell-specific productivity based on cumulative protein as a function of the integral of viable cell count using the method of FIG. 14 compared to traditional fed-batch processes.
  • FIG. 17 is a plot of protein concentration as a function of culture time using the method of FIG. 14 compared to traditional fed-batch processes.
  • FIG. 18 is a schematic of an embodiment of an apparatus and process for performing ATF rapid harvest using continuous feeding with an ultra-filter.
  • DETAILED DESCRIPTION
  • The present disclosure describes the use of alternating tangential flow (ATF) filtration for performing fed-batch harvesting. The use of ATF for harvesting fed-batch cultures allows for a rapid harvest procedure carried out in a single process step, processing a batch with a single set of equipment with a single product as a processed material. These methods are successful when using ATF, compared to other tangential flow filtration methods due to the ability to perform product harvesting at a higher filter flux with ATF.
  • Alternating tangential flow (ATF) has been used to perform filtration and separate cells from product in a single step, but is normally limited to a filter flux of 1.3-5.7 LMH, which is too slow to be useful in a commercial culture harvest setting. Unexpectedly, when ATF filtration was performed at a higher flux (e.g., greater than 10 LMH) as described herein, the filter did not foul and a rapid recovery of product from a culture was obtained in a short processing time. This rapid harvest of a culture with ATF has utility in commercial processes as an economically advantageous way to obtain a clarified feed stream suitable for further processing in a single step.
  • The new methods also simplify the harvest procedure, which heretofore has generally required two or more steps such as centrifugation followed by depth filtration. ATF harvesting as described herein results in a feed stream that can be used directly in the next stage, e.g., to a chromatography column, with high clarity and thus avoids downstream fouling, e.g., of the chromatography column, without the need for any other filtration or other clarification step.
  • During fed-batch culture, biotechnological processes are leveraged to create a desired product. During the culture, one or more nutrients necessary for cell growth and product, this may include, for example, any desired cellular product including endogenous and recombinant products including proteins, nucleic acids, virus, and other molecules of value, formation are fed or supplied to the bioreactor during cultivation. This feeding is performed either continuously or intermittently via one or more feed streams during the course of an operation. There are no effluent streams during the course of operation, so the volume of liquid and cells within the bioreactor increases during the operation. The bioreactor products remain in the bioreactor until the end of the run when they are harvested, typically after 5 to 30 days, e.g., 7 to 25, or 10 to 21 days of culture. Harvesting of fed batch cultures is best performed with little damage to cells in the broth, rapidly to provide efficient processing without product modification and with clarification needed for further processing of a product by chromatography. ATF is uniquely able to support these requirements.
  • Historically, ATF has been used in perfusion culture systems in which cell media is continually supplied to the bioreactor containing the cells and the ATF continually filters the culture, removing culture waste materials and protein product using a microfiltration membrane. This process allows protein to be harvested continuously or at frequent intermittent intervals, and at low filter flux (1.3-5.7 LMH) for the cultivation period that lasts 30 days or even longer. This process is carried out at high cell densities (e.g., 50-150E6 cells/mL or higher). These ATF assisted perfusion cultures can also be performed with an ATF containing an ultrafilter (e.g., nominal pore size 50 kD or smaller) during which waste materials are removed but the product is retained within the culture broth. These cultures are operated at a low filter flux. These are sometimes referred to as concentrated fed batch (CFB) as the desired cellular products are retained in the cell broth as removal of waste products permits a much higher concentration of cells and therefore a higher concentration of desired product.
  • In the present methods, rather than using ATF at a low flux continual cell culturing, the ATF process is instead adapted to serve as rapid harvesting equipment (replacing depth filtration and centrifugation) on a fed-batch culture. In the new processes, ATF is used differently with a high filter flux on the day of harvesting the fed-batch culture, with cell densities that usually range from 7-20E6 cells/ml or a CFB culture with cell densities ranging from 50-200E6 cells/ml (e.g., between 75-120E6 cells/ml). Unlike a traditional perfusion system, in the new processes the product, e.g., protein, is harvested at a high filter flux. The use of an ATF system as rapid harvesting equipment on a fed-batch or CFB bioreactor can overcome the aforementioned issues as this entire harvesting process maintains high cell viability and better product quality.
  • The methods are embodied in four different rapid harvesting techniques for fed-batch and concentrated fed-batch bioreactors that include:
  • (1) ATF rapid harvesting using step-diafiltration (for traditional fed-batch cultures),
  • (2) ATF rapid harvesting using continuous-diafiltration (for traditional fed-batch cultures; more efficient and less time consuming than step-diafiltration),
  • (3) ATF rapid harvesting using continuous diafiltration (for concentrated fed-batch cultures; more efficient and less time consuming), and
  • (4) ATF rapid harvesting with continuous feeding (more efficient and less time consuming with increased protein yield). The procedures for these four different methods are described in greater detail below.
  • Rapid Harvest Using Step-Diafiltration
  • An ATF system with a hollow fiber porous membrane (e.g., microfiltration pore sizes such as 0.1-5.0 micron or ultrafiltration membranes such as 750 kDa MWCO) is well suited for harvesting a fed-batch culture because it retains cells and also other small particulates, which are necessary to remove before downstream processes. Using ATF also reduces cross-contamination as the harvesting can be carried out in a sterile manner, unlike centrifugation or depth filtration.
  • As shown in FIG. 1, an ATF harvest bioreactor system 200 includes a bioreactor 210, which can be, for example, a stirred tank reactor. The bioreactor 210 is connected via a drain tube 212 to an ATF 220. The ATF is a system such as ones used to perfuse a bioreactor culture using hollow fiber filtration using alternating tangential flow. The ATF 220 includes a device that controls a diaphragm pump 222 to perform ATF through a hollow fiber filter 224 (see, e.g., U.S. Pat. No. 6,544,424) both of which are encased in a sterilizable housing 226.
  • Medium and additives are introduced into the bioreactor 210 via a feed line 214, which is controlled by a valve and/or pump 216. An air supply source and the controller 240 (FIG. 6) are connected to the diaphragm pump 222 via an air tube 228. Air is added and withdrawn from the diaphragm pump 222 so as to increase and decrease the volume of the two chambers contained within the diaphragm pump, altering the pressure within the housing 226 and directing flow of the fluid contained within the housing 226 and drawing fluid across the membrane of the hollow fiber filter 224. Typically, the interior portion of the hollow fibers is fluidly connected to the bioreactor via drain tube 212 while the chamber outside the hollow fibers of the hollow fiber filter 224 and within the housing 226 is fluidly connected to a product drain tube 230. The product drain tube 230 has a harvest pump/valve 232 that controls withdrawal of the products that filter across the hollow fiber filter and reside in the chamber between the hollow fiber filter 224 and housing 226. In FIG. 1, the product drain tube 230 is shown near the top of the ATF 220, however the product drain tube 230 could also be located near the middle or bottom of the ATF 220. Alternatively, there may be more than one product drain tube 230 connected to the housing 226.
  • To carry out the rapid harvest using the ATF harvest bioreactor system 200, the product (e.g., the protein) is harvested using ATF at a rapid flux greater than 10 but not greater than 30 liters/meter2/hour (LMH) (for example from 12-18 LMH, 13-16 LMH, or 15 LMH). The rapid harvest can be accomplished by cyclical removal of volume from the culture vessel and refilling (batch filtration) or by continually replenishing the liquid in the culture broth while harvesting liquid through the filtration process (constant volume diafiltration). Both approaches are described below and in the specific examples. It is practical in most bioreactor designs to only be able to remove approximately 80% of the volume and still maintain adequate stirring thus while some reactors may allow greater than 80% most generally, removal of 80% or less in the batchwise or cyclical method of filtration will be described.
  • For a 500 L amount of medium in a 600 L bioreactor (shown as 6 L in FIG. 1), the 15 LMH flux results in a drain time of approximately 2.1 to 2.5 hours in the present methods (assuming an ATF filter size of 11 m2). This draining of the protein continues until the remaining volume in the bioreactor 210 volume drops down to, for example, 30% although other volume decrease values can be used (e.g., 20%). At this bioreactor volume, the harvest pump 232 is paused. The cells all remain in the bioreactor 210 and are within a media broth that is then filled to approximately the same amount of fluid as at the initiation of the harvest. In some instances, the media broth is then filled to a lower amount or a greater amount of fluid as the initiation of the harvest. The fluid could be sterile phosphate buffered saline (PBS) or culture media or other fluid compatible with a viable cell broth. The harvesting drain process resumes at flux of approximately 15 LMH until the volume in the bioreactor 210 again drops to approximately 30%. This cycle is repeated a third and fourth time, if desired or required. Approximately 96% of protein from the fed-batch culture originally contained within the bioreactor 210 is recovered and cell viability maintained.
  • The steps of the rapid harvest procedure are summarized in FIG. 2. When the fed-batch culture has completed, harvest starts at step 150. The harvest is carried out using ATF to drain the cell broth at a flux between 10-30 LMH (e.g., 15 LMH) until the volume of the bioreactor 110 is reduced to 10-50% or more preferably 20-30% of its initial volume, step 160. At this bioreactor volume, the harvest pump 232 is paused, and the operator determines whether the desired recovery has been achieved at step 170. This can be measured by number of drain/refill cycles (e.g., 2 or 3) or other means such as assaying the total amount or concentration of the harvested product. If the harvest is to continue, the bioreactor 210 is refilled at step 180, returning to the drain step 160 and ultimately to harvest completion at step 190.
  • Rapid Harvest Using Continuous Diafiltration
  • In another embodiment, a rapid ATF harvest procedure using continuous diafiltration is shown in FIG. 7. This method of constant volume diafiltration, in some instances, provides a higher yield with less volume than the batchwise method. Testing for both methods for yield and time could be carried out to choose the best method for a given application. The components for harvesting with ATF continuous diafiltration are similar to those shown in FIG. 1. For this procedure, the ATF harvest bioreactor system 300 includes a bioreactor 310 connected via a drain tube 312 to an ATF 320. The ATF 320 includes a device that controls a diaphragm pump 322 to perform ATF through a hollow fiber filter 324 both of which are encased in a sterilizable housing 326.
  • Medium and additives are introduced to the bioreactor 310 via a feed line 314, which is controlled by a valve and/or pump 316. An air supply source and controller (not shown) are fluidly connected to the diaphragm pump 322 via an air tube 328. The interior portion of the hollow fibers (retentate) is connected to the bioreactor 310 via drain tube 312 while the chamber outside the hollow fibers of the hollow fiber filter 324 and within the housing 326 is connected to a product drain tube 330 (permeate). The product drain tube 330 has a harvest pump/valve 332 which controls withdrawal of the products within the permeate.
  • In this process, the protein is also harvested using the ATF 320 at a flux of 10-30 LMH (generally 12-18 or 15 LMH) until the volume of the bioreactor 310 drops down to a volume in which the elevated flux can be maintained for up to 4 bioreactor volumes of fluid transfer by filtration. The percentage of volume reduction may be 0-100%, for example, 30% for fed batch cultures or 0-50% for CFB cultures. In some instances, the percentage of volume reduction is, for example, 10-90%, e.g., 25-75%, e.g., 30-60%, e.g., 5, 10, 15, 20, 25, 30, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, or 100%. For a 500 L bioreactor 310, the 15 LMH flux through an 11 m2 filter results in a drain time to the 30% level of approximately 2.1 hours.
  • Once having reached this reduced bioreactor volume (e.g., 1.8 L), a diafiltration process is started to maintain the bioreactor volume by either addition of PBS or culture media (or other fluid compatible with maintaining cell viability) via the feed line 314 at flow rate equivalent to the fluid harvest rate via the product drain tube 330 (the permeate). This diafiltration process can occur at a flux of, for example, 15 LMH until the yield of desired product in the permeate reaches greater than 90%. Rapid harvesting by this method is therefore completed in less than approximately 6-8 hours (e.g., less than 6 hours).
  • Using either batchwise washing with collection of the permeate or constant diafiltration the rapid harvest of product from a fed batch or CFB culture can be achieved.
  • The steps of the rapid harvest procedure using continuous diafiltration are summarized in FIG. 8. When the fed-batch culture has completed, harvest starts at step 250. The harvest is carried out using ATF to drain the cell broth at a flux of from 10-30 LMH (e.g., 15 LMH) until the volume of the bioreactor 310 is approximately 30% its initial volume, step 260. At this bioreactor volume, the flow rate of the harvest pump 332 is reduced while fluid is added to the bioreactor 210 via the feed line 214 at approximately the same rate (e.g., 15 LMH) to complete a diafiltration cycle, step 270. Once a diafiltration cycle is complete by cycling through an entire displaced volume it is decided (at step 280) if the harvest is to continue (e.g., not yet 90% or 96% recovery) and the system returns to step 270 to perform an additional diafiltration cycle. Once the desired volume has been achieved the harvest operation is completed at step 290.
  • Rapid Harvest Using Continuous-Diafiltration for Concentrated Fed-Batch
  • In another embodiment, a rapid ATF harvest procedure using continuous diafiltration for concentrated fed-batch systems is shown in FIG. 12. The process of ATF rapid harvest for concentrated fed-batch (CFB) depends on viable cell density on the day of harvest. The components for harvesting with ATF continuous diafiltration are similar to those shown in FIG. 1.
  • As shown in FIG. 12, an ATF harvest bioreactor system 400 includes a bioreactor 410, which can be, for example, a stirred tank reactor. The bioreactor 410 is connected via a drain tube 412 to an ATF 420. The ATF is a system such as ones used to perfuse a bioreactor culture using hollow fiber filtration using alternating tangential flow. The ATF 420 includes a device that controls a diaphragm pump 422 to perform ATF through a hollow fiber filter 424 (see, e.g., U.S. Pat. No. 6,544,424) both of which are encased in a sterilizable housing 426.
  • Medium and additives are introduced into the bioreactor 410 via a feed line 414, which is controlled by a valve and/or pump 416. An air supply source and controller (not shown) are fluidly connected to the diaphragm pump 422 via an air tube 428. Air is added and withdrawn from the diaphragm pump 422 so as to increase and decrease the volume of the two chambers contained within the diaphragm pump, altering the pressure within the housing 426 and directing flow of the fluid contained within the housing 426 and drawing fluid across the membrane of the hollow fiber filter 424. Typically, the interior portion of the hollow fibers is fluidly connected to the bioreactor via drain tube 412 while the chamber outside the hollow fibers of the hollow fiber filter 424 and within the housing 426 is fluidly connected to a product drain tube 430. The product drain tube 430 has a harvest pump/valve 432 that controls withdrawal of the products that filter across the hollow fiber filter and reside in the chamber between the hollow fiber filter 424 and housing 426.
  • In FIG. 12, the product drain tube 430 is shown near the top of the ATF 420, however the product drain tube 430 could also be located near the middle or bottom of the ATF 420. Alternatively, there may be more than one product drain tube 430 connected to the housing 426.
  • If the viable cell density (VCD) is below 100E6 cells/mL on the day of harvest at the end of concentrated fed-batch bioreactor 410 culture, the protein is harvested using the ATF 420 at a flux of 10-30 LMH (generally 12-18, 13-16, or 15 LMH) until the volume of the bioreactor 410 drops down to a volume in which the elevated flux can be maintained for up to 4 bioreactor volumes of fluid transfer by filtration. This may be 0-50%, for example 50%, depending on the cell density.
  • Once having reached this reduced bioreactor volume a continuous diafiltration process is started to maintain the bioreactor volume by either addition of PBS or culture media (or other fluid compatible with maintaining cell viability) via the feed line 414 at flow rate equivalent to the fluid harvest rate via the product drain tube 430 (the permeate). This diafiltration process can occur at a flux of, for example, 10-30 LMH until the yield of desired product in the permeate reaches greater than 90%. Rapid harvesting by this method is therefore completed in less than approximately 6-8 hours (e.g., less than 6 hours).
  • It is recommended not to concentrate the cell density when the VCD is already above 100E6 cells/mL on the day of harvest. Referring to FIG. 13, in this case there will be no reduction in bioreactor volume before continuous diafiltration. A continuous diafiltration process is started to maintain the bioreactor volume at 100% by either addition of PBS or culture media (or other fluid compatible with maintaining cell viability) via the feed line 414 at flow rate equivalent to the fluid harvest rate via the product drain tube 430. This diafiltration process can occur at a flux of, for example, 10-30 LMH until the yield of desired product in the permeate reaches greater than 90%, e.g., after 4 bioreactor volume exchanges. After 4 volume exchanges the remaining media will be harvested in exchange with either PBS or fresh media.
  • The following Table 1 shows a suggested reduction in bioreactor volume depending on the cell density on the day of harvest (which can be determined by known measurement techniques).
  • TABLE 1
    Bioreactor Volume Management
    VCD % Reduction in BR Flux
    (10e6 Cells/mL) volume (LMH)
    <30  10%-30% 10-30
    50-100  0%-50% 10-30
    >100 0%  5-30
  • These methods provide a new way to operate cell bioreactor harvest in which an ATF instrument is operated at an increased flux from normal operation. This unique approach can attain rapid harvest that was not possible before. The features of this process are: a single process step to attain a particle free feed stream and the speed at which product harvest can occur. These features provide significant economic benefit in biologic manufacturing processes due to reduced processing time and reduced equipment costs for multiple processing steps.
  • ATF Rapid Harvest Using Continuous Feeding
  • A fed-batch with continuous feeding and rapid harvest process was developed to further shorten the harvesting time. This technique both shortens the harvest time by half and increases protein production while maintaining cell viability to assure high product quality. Increased protein production during harvest is not achievable by currently existing commercially available fed-batch harvest techniques. The increased productivity is especially advantageous since it is accomplished without a change in basic equipment used in fed batch culturing such as the bioreactor or control systems for cell culture.
  • Continuous slow feeding of a fed-batch bioreactor during the final days of cultivation boosts the protein production without adding additional time to the fed-batch cultivation and harvest processes. This can be accomplished using either a microfilter (collection of the product in the permeate) or with an ultrafilter (retention of the product in the reactor where it will be collected during the final harvest stage). Moreover, the continuous harvest process also increases the viability of a fed-batch culture, which is favorable to protein quality. This process reduces cross contamination as the entire process is conducted in a sterile manner, unlike centrifugation or depth filtration.
  • FIG. 14 shows a schematic for the apparatus for use with the fed-batch with continuous feeding & rapid harvest using ATF method. The components for harvesting with ATF continuous diafiltration are similar to those shown in FIG. 1.
  • As shown in FIG. 14, an ATF harvest bioreactor system 500 includes a bioreactor 510, which can be a stirred tank reactor. The bioreactor 510 is connected via a drain tube 512 to an ATF 520. The ATF 520 includes a device that controls a diaphragm pump 522 to perform ATF through a hollow fiber filter 524 both of which are encased in a sterilizable housing 526. Medium and additives are introduced into the bioreactor 510 via a feed line 514, which is controlled by a valve and/or pump 516. An air supply source and controller are fluidly connected to the diaphragm pump 522 via an air tube 528. Air is added and withdrawn from the diaphragm pump 522 so as to increase and decrease the volume of the two chambers contained within the diaphragm pump, altering the pressure within the housing 526 and directing flow of the fluid contained within the housing 526 and drawing fluid across the membrane of the hollow fiber filter 524. Typically, the interior portion of the hollow fibers is fluidly connected to the bioreactor via drain tube 512 while the chamber outside the hollow fibers of the hollow fiber filter 524 and within the housing 526 is fluidly connected to a product drain tube 530. The product drain tube 530 has a harvest pump/valve 532 that controls withdrawal of the products that filter across the hollow fiber filter and reside in the chamber between the hollow fiber filter 524 and housing 526.
  • Continuous feeding can take place in low volume (less than 1.0 vessel volume exchanged per day (VVD), e.g., less than 0.7 VVD), and for a variable number of days (for example 2-8 days) prior to performing the rapid harvest. In one preferred embodiment a continuous slow feeding and harvesting (@ 0.5 VVD) takes place from day 11 to day 14 of cultivation. After the 72 hours simultaneous feeding and harvesting as rapid harvest occurs. The protein is harvested using the ATF 520 at a flux of 10-30 LMH (generally 12-18, 13-16, or 15 LMH) until the volume of the bioreactor 510 drops down below 20% (preferably <10%), substantially harvesting the liquid portion of the bioreactor. The rapid harvest part of the process takes approximately 3 hours to complete for the size bioreactor shown.
  • The continuous feeding and rapid harvest process has significant advantages. The methods described earlier in this disclosure require 14 days culture and approximately 6 hours of additional harvest time, resulting in final amount of recovered protein. In the continuous feeding and rapid harvest process using ATF there are 11 days of regular culture followed by 3 days continuous feed/harvest (for the same total of 14 days) follow by only 3 hours of rapid harvest. This process results in an increased amount of protein recovered in substantially the same amount of time from the same bioreactor equipment used in fed batch culture production. In addition, the continuous feed during low volume harvest prior to rapid harvest maintains or improves cell viability and product quality better than currently available process technology.
  • In all of the embodiments described for rapid harvest the final product pool can further be concentrated by use of the ATF with an ultrafilter to reduce volume for subsequent additional processing or storage of the product.
  • EXAMPLES
  • The invention is further described in the following examples, which do not limit the scope of the invention described in the claims.
  • 1) ATF Rapid Harvest Using Step-Diafiltration—Traditional Fed-Batch
  • A variety of testing and experimental procedures were required to improve a fed-batch rapid harvesting system with use of ATF step-diafiltration. Examples include a 6 L fed-batch bioreactor (with an ATF2 system from Repligen Corp., Waltham Mass.) for rapid harvesting. ATF2 data was used to extrapolate to a 1000 L fed-batch bioreactor (with an ATF10 system from Repligen Corp., Waltham Mass., a commercially available perfusion product for 500 L and 1000 L bioreactors).
  • Testing was also carried out to determine the percentage recovery and total harvest time for this method. For this testing, a frozen vial of LONG®R3IGF-1 adapted CHO DP12 cells was thawed and grown in 125 mL shake flask (working volume 40 mL) containing CD OptiCHO® medium with 100 ng/mL LONG®R3IGF-1, 200 nM Methotrexate and 4 mM Glutamax®. After 4-6 days, the cells were passaged/sub cultured again into a 1 L (working volume 200 mL) shake flask in order to generate sufficient number of cells to be inoculated into the bioreactor. Once the density reached 5-7E6 cells/mL, the cells were inoculated into 3 L bioreactor (working volume 1.5 L) assembled with SS-ATF2. Feeding strategies and bioreactor conditions for fed-batch bioreactor are described in the Tables 2 and 3.
  • TABLE 2
    Fed-Batch Conditions
    Fed-Batch Conditions
    Cell Lines CHO DP12 (ATCC CRL-12445 ™)
    Media CD OptiCHO ™ Medium
    Media supplements LONG ®R3 IGF-I (100 ng/mL)
    Methotrexate (200 nM)*
    Glutamax (4 mM)
    Feeds Day 3: Feed A (5%) + Feed B (5%)
    Day 6: Feed A (5%) + Feed B (5%)
    Day 9: Feed A (5%) + Feed B (5%)
    Day 12: Feed A (5%) + Feed B (5%)
    Glucose Feeds No glucose feeds
    (Feeds already contain high concentrations)
    Seeding Density 0.4E6/mL
    Working Volume (Day 0) Bioreactor: 1200 mL
    Working Volume (End day) Bioreactor: 2000 mL
    Antibody Product Human Anti-IL-8
    Note*:
    Methotrexate was used only for seed expansion and not in the Fed-batch cultures
  • TABLE 3
    Bioreactor Conditions
    Bioreactor Conditions
    Conditions Mode Set point Controlled by
    Temperature AUTO 37° C. Heating Blanket
    Agitation AUTO
    280 rpm Stirrer
    pH AUTO 6.8-7.2 CO2 and
    DO AUTO 40% O2 supplement
    Air Manual
    500 mL/min Constant
  • On day 14, at the end of fed-batch culture the harvesting process was started at ATF rate of 0.9 LPM and a flux of 15 LMH. After each cycle (as shown in FIG. 1), the bioreactor was filled with sterile PBS back to 100%, and a second harvesting cycle was started at same flux to recover the remaining amount of IgG. Similarly, another cycle (total 3 cycles) was repeated in similar fashion.
  • FIG. 3 shows the resulting plot of viable cell density (VCD) and viability as a function of culture time. These are typical profiles in fed-batch cultures and generally the viability on the day of harvest varies between 60-85%. The maximum VCD was ˜14 E6 cells/mL and the VCD at the day of harvest was 9-10E6 cells/mL.
  • FIG. 4 is a plot of concentration of protein in fed-batch culture from day 1 through day 14. The final concertation of protein on the day of harvest was ˜600 mg/L and this was used as an initial concertation before starting the rapid harvest process.
  • FIG. 5 is a plot of cell-specific productivity or cumulative protein as a function of cell growth over time, i.e., the integral of viable cells (IVC). The linear plot between IVC and cumulative protein indicates that cells specific productivity remains approximately the same throughout the fed-batch process.
  • Generally in fed-batches, harvest clarification is achieved by centrifugation followed by depth filtration. This is a two-step process as usage of depth filter alone is currently unable to handle high-solids feed streams (especially when cell densities are high) and are often have to use in series with centrifugation. In addition, depth filtration has limitations in terms of scale-up and monitoring differential pressures.
  • On the other hand, using ATF step-diafiltration, the entire process can be combined to a single step with shorter duration. ATF with 0.2 μm micro filter is well suited for harvesting a fed batch culture because it retains cells and also other small particulates, which are beneficial for downstream processes. Using ATF also reduces cross contamination as the harvesting can be conducted in a sterile manner. The commercially available ATF10 system can provide ATF perfusion for 500 L and 1000 L bioreactors, and can be used in multiples to easily scale up to 2000 L bioreactors. Based on the data described herein, protein recoveries can be over 95% using rapid harvest using step-diafiltration.
  • The overall time for harvesting process using ATF step-diafiltration is less than 8 hours. No significant drop in viability indicates that protein quality does not alter during harvesting process. The resulting viability and IgG concentrations after each cycle of harvesting are shown in Table 4 below. After each cycle, samples were collected from the bioreactor to measure viability and protein concentrations. No sample was collected after the first cycle (ND=Not Determined).
  • TABLE 4
    Viability and IgG Concentrations
    Titer in Time
    Conditions % Viability BR % Recovery (hrs.)
    End of FB-Day 14 80 587 NA NA
    After 1st Cycle ND ND ND 2-2.5
    After 2nd Cycle 75 98 83% 2-2.5
    After 3rd Cycle 71 21.5 96% 2-2.5
  • Two ATF10 bioreactors can be run simultaneously. Each ATF10 has 11 m2 surface area and when they are used simultaneously the total combined area is 22 m2. The total harvesting time can be further shortened by increasing the number of ATF10 devices from 2 to 3 or more.
  • The following Table 5 was tabulated based on the surface area from ATF2 to mid-sized (2.5 m2 surface area) ATF6 to the ATF10.
  • TABLE 5
    Scale-Up Calculations
    ATF ATF Rapid harvest process Total Final
    Fed- SA Flux 1st 2nd 3rd Cycle: Time Harvest
    Batch BR ATF (M2) (LMH) Cycle: Cycle: Vol down for Volume
    6 ATF2 0.13 15 147.7 147.7 147.7 7.4 14.4
    115 ATF6 2.5 15 147.2 147.2 147.2 7.4 276
    500 ATF10 11 15 145.5 145.5 145.5 7.3 1200
    1000 ATF10 11 15 290.9 290.9 290.9 14.5 2400
    1000 2XATF10 22 15 145.5 145.5 145.5 7.3 2400
    2000 2XATF10 22 15 290.9 290.9 290.9 14.5 4800
    2000 4XATF10 44 15 145.5 145.5 145.5 7.3 4800
  • In these experiments, ATF2 with a 6 L fed-batch bioreactor at a flux of 15 LMH was successfully demonstrated to harvest protein in less than 8 hours with recovery of 96% of the product. Extrapolating the surface area from ATF2 (0.13 m2) to ATF10 (11 m2), allows one to predict that a 500 L fed-batch bioreactor can be rapidly harvested within 8 hours using an ATF10 according to the methods described herein. Similarly, a 1000 L fed-batch bioreactor can be harvested in 8 hours using two ATF10s (total filter surface area (SA): 22 m2). In addition, there was minimal loss in viability during the harvesting process.
  • 2) ATF Rapid Harvest Using Continuous Diafiltration—Traditional Fed-Batch
  • To evaluate the rapid harvesting technique, a 2 L fed-batch bioreactor connected to ATF2 was used to mimic a 6 L fed-batch bioreactor using a scale down model (SDM), recirculation approach. A 6 L bioreactor with ATF2 data was used to extrapolate to 500 L and 1000 L fed-batch bioreactor using an ATF10.
  • Testing was also carried out to determine the percentage recovery and total harvest time for this method, similar to in the previously described method.
  • FIG. 9 shows the resulting plot of viable cell density (VCD) and viability as a function of culture time. These are typical profiles in fed-batch cultures and generally the viability on the day of harvest varies between 60-85%. The maximum VCD was ˜14E6 cells/mL and the VCD at the day of harvest was 9-10E6 cells/mL.
  • FIG. 10 is a plot of protein or titer content is a plot of concentration of protein in fed-batch culture from day 1 through day 14. The final concertation of protein on the day of harvest was ˜600 mg/L and this was used as an initial concertation before starting the rapid harvest process.
  • FIG. 11 is a plot of cell-specific productivity or cumulative protein as a function of cell growth over time, i.e., the integral of viable cells (IVC). The linear plot between IVC and cumulative protein indicates that cells specific productivity remains same throughout the fed-batch process.
  • Generally, in fed-batches, harvest clarification is achieved by centrifugation followed by depth filtration. This is a two-step process as usage of depth filter alone is currently unable to handle high-solids feed streams (especially when cell densities are high) and are often have to use in series with centrifugation. In addition, depth filtration may have limitations in terms of scale-up and monitoring differential pressures.
  • On the other hand, using ATF continuous-diafiltration, the entire process can be combined to a single step with even shorter duration than the ATF step-diafiltration process. ATF with 0.2 μm microfilter is well suited for harvesting a fed batch culture because it retains cells and also other small particulates, which if removed are beneficial for downstream processes. Using ATF also reduces cross contamination as the harvesting can be demonstrated in a sterile manner. The systems described herein can be scaled up to 500, 1000, 1500, or 2000 L, for example, using two or more ATF10 perfusion products (Repligen, Waltham Mass.). Based on the data described herein, the protein recoveries can be better than 95% using rapid harvest using step-diafiltration.
  • The overall time for harvesting process using ATF continuous diafiltration is less than 6 hours. No significant drop in viability indicates that protein quality does not alter during harvesting process.
  • The resulting recovery and IgG concentrations after each cycle of harvesting are shown in Table 6 below.
  • TABLE 6
    Recovery and IgG Concentrations
    Total Protein
    Conditions Volume (mL) IgG Conc (mg)
    BR-Before Harvesting 1600 635.1 1016.2
    Harvest bag- After 3250 297.5 966.9
    Completion of rapid
    harvest
    Recovery Recovery 95%
  • The recovery of protein after rapid harvest using continuous diafiltration is shown in Table 7 below.
  • TABLE 7
    Protein Recovery
    Time BR Volume + % Via- Titer in
    (Hrs) ATF bility BR (mg/L) Flux
    Process Day
    14 1600 77 635.1 NA
    Fed-Batch
    Volume 0.17 1513 79.6 636.9 15
    down 1.00 1160 69.4 638.7 15
    To 30% 2.00 550 73.7 658.4 15
    Diafiltration
    Continuous 3.33 550 73 178.3 15
    Diafiltra- 4.67 550 72.9 43.0 15
    tion at 6.00 550 70.6 16.23 15
    30% volume
  • Data using the ATF2 and ATF6 results were extrapolated to the larger ATF10. It was determined that a 500 L fed-batch bioreactor can be harvested in less than 6 hours using ATF10, and 1000 L fed-batch bioreactor can be harvested with two ATF10s (total filter surface area (SA): 22 m2). Table 8 was tabulated based on the surface area from ATF2 to ATF6 to ATF10.
  • TABLE 8
    Scale up
    ATF Rapid Harvest Process
    Before Total Final
    Fed- ATF Difiltr. Vol Continuous-Diafiltration Time for Harvest
    Batch SA Flux down to 30% (4 cycles) harvest Volume
    BR(L) ATF (m2) (LMH) (hr) 1st 2nd 3rd 4th (hr) (L)
    6 1XATF2 0.15 15 2.15 0.9 0.9 0.9 0.9 5.8 11
    115 1XATF6 2.5 15 2.15 0.9 0.9 0.9 0.9 5.8 219
    500 1XATF10 11 15 2.12 0.9 0.9 0.9 0.9 5.8 950
    1000 1XATF10 11 15 4.24 1.8 1.8 1.8 1.8 11.5 1900
    1000 2XATF10 22 15 2.12 0.9 0.9 0.9 0.9 5.8 1900
    2000 2XATF10 22 15 4.24 1.8 1.8 1.8 1.8 11.5 3800
    2000 4XATF10 44 15 2.12 0.9 0.9 0.9 0.9 5.8 3800
  • ATF2 with a 6 L fed-batch bioreactor at a flux of 15 LMH was successfully demonstrated to harvest protein in less than 6 hours with recovery of 95%. Extrapolating the surface area from ATF2 (0.13 m2) to ATF10 (11 m2), allows one to predict that a 500 L fed-batch bioreactor can be rapidly harvested within 6 hours using an ATF10. Similarly, a 1000 L fed-batch bioreactor can be harvested in 6 hours using two ATF10s. In addition, there was no significant loss of viability during harvesting process.
  • 3) ATF Rapid Harvest Using Continuous Diafiltration—Concentrated Fed-Batch
  • In CFB, it is recommended to drop the bioreactor volume only when VCD is less than 100E6 cells/mL. The following two tables were tabulated based on the surface area scaled from ATF2 to ATF6 to ATF10. The first table, Table 9, is considering the bioreactor volume reduction to 50% before starting the continuous diafiltration process. The second table, Table 10, is without reduction in bioreactor volume, i.e., the diafiltration starts from the beginning.
  • TABLE 9
    Scale Up With 50% Reduction
    ATF Rapid Harvest Process
    Before Total Final
    Fed- ATF Difiltr. Vol Time for Harvest
    Batch SA Flux down to 50% Continuous-Diafiltration harvest Volume
    BR(L) ATF (m2) (LMH) (hr) 1st 2nd 3rd 4th (hr) (L)
    6 ATF2 0.13 15 1.54 1.5 1.5 1.5 1.5 7.7 15
    115 ATF6 2.5 15 1.53 1.5 1.5 1.5 1.5 7.7 287.5
    500 ATF10 11 15 1.52 1.5 1.5 1.5 1.5 7.6 1250
    1000 ATF10 11 15 3.03 3.0 3.0 3.0 3.0 15.2 2500
    1000 2XATF10 22 15 1.52 1.5 1.5 1.5 1.5 7.6 2500
    2000 2XATF10 22 15 3.03 3.0 3.0 3.0 3.0 15.2 5000
    2000 4XATF10 44 15 1.52 1.5 1.5 1.5 1.5 7.6 5000
  • TABLE 10
    Scale Up With 0% Reduction
    ATF Rapid Harvest Process
    Before Total Final
    Fed- ATF Difiltr. Vol Time for Harvest
    Batch SA Flux down to 0% Continuous-Diafiltration harvest Volume
    BR(L) ATF (m2) (LMH) (hr) 1st 2nd 3rd 4th (hr) (L)
    6 ATF2 0.13 15 0.00 3.1 3.1 3.1 3.1 12.3 24
    115 ATF6 2.5 15 0.00 3.1 3.1 3.1 3.1 12.3 460
    500 ATF10 11 15 0.00 3.0 3.0 3.0 3.0 12.1 2000
    1000 ATF10 11 15 0.00 6.1 6.1 6.1 6.1 24.2 4000
    1000 2XATF10 22 15 0.00 3.0 3.0 3.0 3.0 12.1 4000
    2000 2XATF10 22 15 0.00 6.1 6.1 6.1 6.1 24.2 8000
    2000 4XATF10 44 15 0.00 3.0 3.0 3.0 3.0 12.1 8000
  • 4) ATF Rapid Harvest Using Continuous Feeding
  • The FB with continuous feeding and rapid harvest process was developed to further shorten the harvesting time by half and increase protein production. This is achieved through a low volume continuous feed prior to rapid harvest together with a high flux rapid harvest. In the example described below a 40% increase in protein yield was obtained compared to currently existing commercially available fed-batch harvest techniques. In this example of continuous feeding and rapid harvest process using ATF there are 11 days of regular culture as described in other examples, followed by 3 days continuous feed/harvest (for the same total of 14 days) follow by only 3 hours of rapid harvest. Other embodiments could change the length of time for the continuous feed or the volume of the continuous feed to obtain similar improvements in cell viability and total protein production. For these tests a 2 L bioreactor with recirculation method was used to mimic 6 L fed-batch bioreactor, and flux was maintained at 15 LMH using recirculation approach.
  • FIG. 15 shows the resulting plot of viable cell density (VCD) and viability as a function of culture time for both continuous feeding and traditional fed-batch. Both VCD and viability showed increasing trends following the onset of continuous feeding and harvest on day 11. FIG. 16 is a plot of cell-specific productivity or cumulative protein as a function of cell growth over time, i.e., the integral of viable cells (IVC) for both processes. FIG. 17 is a plot of protein in fed-batch culture from day 1 through day 14 showing increased total accumulation after continuous feeding and harvest started on day 11 compared to traditional fed-batch.
  • Table 11 shows the conditions used for the fed-batch harvest culture.
  • TABLE 11
    Fed-Batch conditions
    Fed-Batch Conditions
    Improved Fed-Batch
    with continuous feeding &
    Bioreactors Traditional Fed-batch rapid harvest using ATF
    Cell Lines CHO DP12 (ATCC CRL-12445 ™)
    Media CD OptiCHO ™ Medium
    Media LONG ®R3 IGF-I (100 ng/mL)
    supplements Methotrexate (200 nM)*
    Glutamax (4 mM)
    Feeding Day 3: Feed A (5%) + Feed B (5%)
    Strategies Day 6: Feed A (5%) + Feed B (5%)
    Day 9: Feed A (5%) + Feed B (5%)
    Day 12: Feed A Day 11-Day 14: 0.5
    (5%) + Feed B VVD perfusion rate for
    (5%) continuous harvest
    Day 14: 15 LMH for
    rapid harvest (no media feed)
    Glucose Feeds No glucose feeds
    (Feeds already contain high concentrations)
    Seeding Density 0.4E6/mL
    Working Bioreactor: 1200 mL
    Volume
    (Day 0)
    Antibody Human Anti-IL-8
    Note*:
    Methotrexate was used only for seed expansion and not in the Fed batch cultures
  • The resulting viability after each 0 to 3 hours of harvesting are shown in Table 12 below. VCD & viability measurements were conducted at approximately at 2.7 hours.
  • TABLE 12
    VCD and Viability
    Harvaest
    BR Titer Titer % Harvest Bag
    Time Time Volume + % VCD in BR in HL Protein Bag IgG (Volume Harvest
    Process points (Hrs) ATF Viability (E6/mL) (mg/L) (mg/L) Passage Flux Conc. m/L) IgG(g)
    ATF Day 0 hr 1600 71.2 16.82 340.3 328.3 96% NA 415.43 2450 1.02
    Rapid 14 1 hr 1050 70.7 21.11 346.1 328.8 95% 15 398.71 3000 1.20
    Harvest 2 hr  500 72.9 34.1 362.8 334.5 92% 15 391.12 3550 1.39
    3 hr  300* 70.3* 77.13* 403.8 340.3 84% 15 386.11 4000 1.54
  • The following scale up data was extrapolated ATF2 to ATF10 based on the surface area (SA) of filters:
  • TABLE 13
    Scale Up With 0% Reduction
    Time for Final
    Rapid Harvest
    Fed- Harvest Volume (L)
    Batch ATF Flux Permeate Permeate Harvest Harvest @0.5 VVD
    BR(L) ATF SA(m2) (LMH) (L/Day) (mL/MIN) (mL/MIN) (hr) for 3 days
    6 1X ATF2 0.15 15 46.8 32.5 32.5 3.1 15
    115 1X ATF6 2.5 15 900 625 625 3.1 288
    500 1X ATF10 11 15 3960 2750 2750 3.0 1250
    1000 1X ATF10 11 15 3960 2750 2750 6.1 2500
    1000 2X ATF10 22 15 7920 5500 5500 3.0 2500
    2000 2X ATF10 22 15 7920 5500 5500 6.1 5000
    2000 4X ATF10 44 15 15840 11000 11000 3.0 5000
  • The continuous feeding and rapid harvest process showed significant advantages. For this example, 11 days of regular culture followed by 3 days continuous feed/harvest followed by only 3 hours of rapid harvest obtained 1.4 times the amount of protein recovered by a conventional fed batch process. A process that can retain higher cell viability and yield higher protein production than currently available technology is a significant and meaningful process improvement.
  • As shown in FIG. 18, system 600 can carry out a process with continuous feeding while using the ATF equipped with an ultrafilter. Other elements of system 600 are the same as in prior embodiments. The product is retained in the bioreactor and all product is harvested during the rapid harvest phase. This further reduces the volume of the final product pool while still obtaining the increase product yield.
  • The following scale up data was extrapolated:
  • TABLE 14
    Scale Up
    Time for Final
    Fed- Rapid Harvest
    Batch ATF Flux Permeate Permeate Harvest Harvest Volume
    BR(L) ATF SA(m2) (LMH) (L/Day) (mL/MIN) (mL/MIN) (hr) (L)
    6 1X ATF2 0.13 15 46.8 32.5 32.5 3.1 6
    115 1X ATF6 2.5 15 900 625 625 3.1 115
    500 1X ATF10 11 15 3960 2750 2750 3.0 500
    1000 1X ATF10 11 15 3960 2750 2750 6.1 1000
    1000 2X ATF10 22 15 7920 5500 5500 3.0 1000
    2000 2X ATF10 22 15 7920 55000 5500 6.1 2000
    2000 4X ATF10 44 15 15840 11000 11000 3.0 2000
  • Other Embodiments
  • It is to be understood that while the invention has been described in conjunction with the detailed description thereof, the foregoing description is intended to illustrate and not limit the scope of the invention, which is defined by the scope of the appended claims. Other aspects, advantages, and modifications are within the scope of the following claims.

Claims (19)

1. A method of harvesting a cell product from a fed batch culture using an alternating tangential flow (ATF) filter, the method comprising:
producing a cell product in a fed batch culture until the cell product reaches a harvest concentration in the culture medium;
harvesting the cell product by passing the culture medium through an ATF filter such that the cell product passes into a permeate channel of the ATF filter;
wherein if the viable cell density is above a first value, the ATF filter is operated in diafiltration mode at a high filter flux until at least 90% of the cell product is in the permeate, and
wherein, if the viable cell density is below the first value, the ATF filter is operated at a high filter flux in concentration mode until the viable cell density reaches the first value or the culture medium reaches a predetermined volume lower than the starting volume and thereafter operating in diafiltration mode until at least 90% of the cell product is in the permeate.
2. The method of claim 1, wherein harvesting takes less than 18 hours for a volume between 500 liters and 2000 liters.
3. The method of claim 2, wherein harvesting takes less than 6.0 hours.
4. The method of claim 1, wherein the ATF filter comprises a hollow fiber filter.
5. The method of claim 4, wherein the filter has a pore size of approximately about 0.1 to 5.0 microns or about 500 to 1000 kD.
6. The method of claim 1, wherein the cell product is a monoclonal antibody, enzyme, or virus.
7. The method of claim 1 wherein said diafiltration mode is step diafiltration or continuous diafiltration.
8. The method of claim 7, wherein diafiltration uses cell culture medium as a replenishing liquid.
9. The method of claim 7, wherein diafiltration uses phosphate buffered saline as a replenishing liquid.
10. The method of claim 1, wherein the predetermined volume is about 5% to about 30% of the starting volume or about 10% to about 20% of the starting volume.
11. The method of claim 10, wherein the predetermined volume is about 50% of the starting volume.
12. The method of claim 1, wherein said predetermined value for viable cell density is 100e6.
13. A system comprising:
a bioreactor comprising an inlet and an outlet;
a source of fluid medium containing no cell product connected to the bioreactor inlet;
an alternating tangential flow (ATF) device connected to the bioreactor outlet;
a pump connected to an outlet of the ATF device and configured to remove fluid from the ATF device; and
a controller arranged and programmed to perform the method of claim 1.
14. The system of claim 13, wherein the ATF device comprises a hollow fiber filter.
15. The system of claim 14, wherein the filter has a pore size of approximately about 0.1 to 5.0 microns or about 500 to 1000 kD.
16. The system of claim 7, wherein the controller is arranged and programmed to set the predetermined volume to about 5% to about 30% of the starting volume, to about 10% to about 20% of the starting volume.
17. The system of claim 7, wherein the predetermined volume is about 50% of the starting volume.
18. The system of claim 7, wherein the ATF device operating in diafiltration mode is programmed for step diafiltration or continuous diafiltration.
19. The system of claim 7, wherein said predetermined value for viable cell density is 100e6.
US17/731,295 2016-07-25 2022-04-28 Alternating tangential flow rapid harvesting Pending US20220325708A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US17/731,295 US20220325708A1 (en) 2016-07-25 2022-04-28 Alternating tangential flow rapid harvesting

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662366557P 2016-07-25 2016-07-25
US15/659,562 US11339775B2 (en) 2016-07-25 2017-07-25 Alternating tangential flow rapid harvesting
US17/731,295 US20220325708A1 (en) 2016-07-25 2022-04-28 Alternating tangential flow rapid harvesting

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US15/659,562 Continuation US11339775B2 (en) 2016-07-25 2017-07-25 Alternating tangential flow rapid harvesting

Publications (1)

Publication Number Publication Date
US20220325708A1 true US20220325708A1 (en) 2022-10-13

Family

ID=61017487

Family Applications (2)

Application Number Title Priority Date Filing Date
US15/659,562 Active 2038-01-04 US11339775B2 (en) 2016-07-25 2017-07-25 Alternating tangential flow rapid harvesting
US17/731,295 Pending US20220325708A1 (en) 2016-07-25 2022-04-28 Alternating tangential flow rapid harvesting

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US15/659,562 Active 2038-01-04 US11339775B2 (en) 2016-07-25 2017-07-25 Alternating tangential flow rapid harvesting

Country Status (8)

Country Link
US (2) US11339775B2 (en)
EP (1) EP3487609A4 (en)
JP (2) JP7102391B2 (en)
KR (3) KR102539167B1 (en)
CN (2) CN109689191B (en)
AU (1) AU2017301691B2 (en)
CA (1) CA3032099A1 (en)
WO (1) WO2018022661A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109689191B (en) * 2016-07-25 2021-11-19 瑞普利金公司 Alternate tangential flow rapid harvest
CN110241012B (en) * 2018-03-09 2022-11-01 嘉和生物药业有限公司 Production method and production module for upstream staged interception of biomacromolecules and application of production module in production
JP2022532831A (en) * 2019-05-21 2022-07-20 レプリゲン・コーポレーション Alternate tangent flow pumping method
EP4008774A4 (en) * 2019-07-16 2023-09-27 Innovent Biologics (Suzhou) Co., Ltd. Cell culture method and application thereof based on high-density and continuous inoculation
CA3147494A1 (en) * 2019-08-13 2021-02-18 Repligen Corporation Control systems and methods for automated clarification of cell culture with high solids content
EP4073228A4 (en) * 2019-12-13 2023-05-31 Repligen Corporation Alternating tangential flow bioreactor with hollow fiber system and method of use
CN115003787A (en) * 2020-01-15 2022-09-02 上海药明生物技术有限公司 Apparatus and method for continuous harvesting of biological material produced by cultured cells
CN111154647A (en) * 2020-01-17 2020-05-15 英诺维尔智能科技(苏州)有限公司 Closed circulation external exchange biological product reactor
CA3189533A1 (en) 2020-07-28 2022-02-03 Seagen Inc. Methods and systems for producing polypeptides
CN112322496B (en) * 2021-01-05 2021-04-23 北京百普赛斯生物科技股份有限公司 Perfusion production system and method for new coronavirus S1 protein
EP4105311B1 (en) 2021-06-16 2023-11-01 Sartorius Stedim Biotech GmbH Device and method for separating cells from a culture medium in a bioprocess
WO2023190829A1 (en) * 2022-03-31 2023-10-05 富士フイルム株式会社 Product manufacturing method and product
WO2024006893A1 (en) * 2022-06-30 2024-01-04 Genentech, Inc. Systems, apparatus, and methods for cell culture
CN116179464A (en) * 2022-12-06 2023-05-30 无锡药明生物技术股份有限公司 Method for improving cell density of culture solution and culturing high-density cells
WO2024192116A1 (en) * 2023-03-14 2024-09-19 Repligen Corporation High viable cell density transfection

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100098725A1 (en) * 2008-09-24 2010-04-22 Medimmune, Llc Methods for cultivating cells, propagating and purifying viruses
WO2012045769A1 (en) * 2010-10-05 2012-04-12 Novo Nordisk Health Care Ag Process for protein production
WO2014073967A1 (en) * 2012-11-09 2014-05-15 Biosana Pty Ltd. Discontinuous fed batch processing with the use of alternating bioreactors
WO2015188009A1 (en) * 2014-06-04 2015-12-10 Amgen Inc. Methods for harvesting mammalian cell cultures
US11339775B2 (en) * 2016-07-25 2022-05-24 Repligen Corporation Alternating tangential flow rapid harvesting

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023182A (en) * 1988-06-28 1991-06-11 The United States Of America As Represented By The Secretary Of Agriculture Novel virus composition to protect agricultural commodities from insects
US6667176B1 (en) * 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
US6544424B1 (en) * 1999-12-03 2003-04-08 Refined Technology Company Fluid filtration system
EP2014760A1 (en) * 2007-06-13 2009-01-14 CMC Biopharmaceuticals A/S A method for producing a biopolymer (e.g. polypeptide) in a continuous fermentation process
CN103305417A (en) 2012-03-07 2013-09-18 无锡药明康德生物技术有限公司 High-yield reactor for protein production, and production method and application thereof
US20140004097A1 (en) * 2012-06-29 2014-01-02 Shire Human Genetic Therapies, Inc. Method of producing recombinant iduronate-2-sulfatase
CN103157102B (en) * 2012-12-27 2014-12-10 瑞普(保定)生物药业有限公司 Method for preparing duck hemorrhagic ovaritis inactivated vaccines
JP6530171B2 (en) * 2014-09-09 2019-06-12 旭化成メディカル株式会社 Method of collecting culture product
KR102613876B1 (en) * 2015-11-10 2023-12-15 리플리겐 코포레이션 Disposable alternating tangential flow filtration units

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100098725A1 (en) * 2008-09-24 2010-04-22 Medimmune, Llc Methods for cultivating cells, propagating and purifying viruses
WO2012045769A1 (en) * 2010-10-05 2012-04-12 Novo Nordisk Health Care Ag Process for protein production
WO2014073967A1 (en) * 2012-11-09 2014-05-15 Biosana Pty Ltd. Discontinuous fed batch processing with the use of alternating bioreactors
WO2015188009A1 (en) * 2014-06-04 2015-12-10 Amgen Inc. Methods for harvesting mammalian cell cultures
US11339775B2 (en) * 2016-07-25 2022-05-24 Repligen Corporation Alternating tangential flow rapid harvesting

Also Published As

Publication number Publication date
KR20220110865A (en) 2022-08-09
JP7102391B2 (en) 2022-07-19
CN109689191B (en) 2021-11-19
EP3487609A1 (en) 2019-05-29
US20180148677A1 (en) 2018-05-31
EP3487609A4 (en) 2020-04-22
CN109689191A (en) 2019-04-26
JP2022125250A (en) 2022-08-26
KR102427715B1 (en) 2022-08-02
AU2017301691B2 (en) 2022-07-21
US11339775B2 (en) 2022-05-24
KR102539167B1 (en) 2023-06-02
KR20190034241A (en) 2019-04-01
CN114058599A (en) 2022-02-18
AU2017301691A1 (en) 2019-02-14
WO2018022661A1 (en) 2018-02-01
CA3032099A1 (en) 2018-02-01
JP2019523002A (en) 2019-08-22
KR20230080504A (en) 2023-06-07

Similar Documents

Publication Publication Date Title
US20220325708A1 (en) Alternating tangential flow rapid harvesting
US11975293B2 (en) Tangential flow filtration device for perfusion applications
US8679778B2 (en) Method for producing a biopolymer (e.g. polypeptide) in a continuous fermentation process
US4751003A (en) Crossflow microfiltration process for the separation of biotechnologically produced materials
RU2769767C1 (en) Method for step-by-step retention and production module for obtaining biomacromolecules and their application
CN103865792A (en) Circulating microbial fermentation reaction and feed liquid separation integrated equipment
Carstensen et al. Reverse-flow diafiltration for continuous in situ product recovery
Ennis et al. Production of solvents (ABE fermentation) from whey permeate by continuous fermentation in a membrane bioreactor
CN112262209A (en) Cell culture system and cell culture method
US20240254535A1 (en) Systems and methods for cell-free polypeptide synthesis
Dalm et al. Stable hybridoma cultivation in a pilot‐scale acoustic perfusion system: Long‐term process performance and effect of recirculation rate
JP2017511144A (en) High cell density fill and draw fermentation process
CN203820791U (en) Integrated circulating-type microbial fermentation reaction and feed liquid separation device
US20240279590A1 (en) Device arrangement and method of separating cells from a culture medium in a bioprocess
CN213977495U (en) Desalting device for antibiotic fermentation liquor
WO2024006893A1 (en) Systems, apparatus, and methods for cell culture
US20230235263A1 (en) Systems and methods for filtration of cell cultures
EP3772536A1 (en) Method and system for concentrating an algal suspension
WO2024079608A1 (en) Perfusion bioreactor tangential flow filtration
WO2024080892A2 (en) Perfusion filtration system for continuous cultivation of cell cultures
WO2024192116A1 (en) High viable cell density transfection
US20060172376A1 (en) Method and device for the continuous production of biomolecules
Hufford Comparison of the growth and monoclonal antibody production of suspended mammalian cells in three perfusion systems
JPS63160579A (en) Culture of mammal&#39;s cell in suspension culture, apparatus for performing said culture and use thereof for preparing protein
JPH02200176A (en) Cell culture method and system therefor

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

AS Assignment

Owner name: REPLIGEN CORPORATION, MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KUDUGUNTI, SHASHI KIRAN;LIN, WENGLONG ROY;BONHAM-CARTER, JOHN;AND OTHERS;SIGNING DATES FROM 20170828 TO 20170922;REEL/FRAME:060418/0648

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED